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CHAPTER 1
Literature review
B Cells and the B Cell Response
Mammalian B cell ontogeny. It has been well documented that the
sites of primary production of mammalian lymphoid, myeloid and
erythroid precursors, include the bone marrow, liver and spleen in
fetuses, and the bone marrow in adults (Owen et al., 1977; Levitt
and Cooper, 1980; Whitlock et al., 1985). Differentiation of the
lymphoid population then begins in the bone marrow which
produces pre-B and pre-T cells (LePault, 1983). Pre-T cells
subsequently migrate to the thymus, which is the primary site of T
cell development and maturation (Owen, 1972). The population of
immature lymphocytes containing cytoplastmic immunoglobulin M
(cIgM), but lacking detectable surface Ig, termed pre-B cells, have
been found in livers of 11-12 day mice, 7 week human and 21 day
rabbit fetuses several days before surface IgM-positive B cells
appear (Raff et al., 1976; Gathings et al., 1977; Andrew and Owen,
1978; Hayward et al., 1978). These and other studies have provided
evidence that these cells are the precursors of B lymphocytes
(Whitlock et al., 1985; Freitas et al., 1982).
In a normal, unmanipulated adult mouse, the bone marrow
produces very large numbers of B lymphocytes. Although still
debatable, it is believed that the bulk of B cell generation in the2
bone marrow is solely guided by endogenous factors, and is
independent of environmental influences. The rate of bone marrow
B cell production is sufficiently high that within 2-4 days enough
new B lymphocytes are produced to replenish the whole periphery
of the mouse (Freitas et al., 1989; Osmond, 1986). These newly
formed B cells are immunocompetent, express surface Ig, and
respond to activation stimuli. These B cells subsequently migrate to
the peripheral blood, lymph nodes and spleen, where upon further
maturation, become surface IgM+ / IgD+, sensitive to antigen and
mitogen activation, and are found in the adult spleen as the primary
resting B-cell population.
Mammalian B cell response. The entire sequence of events leading
to a B cell response to antigen is generally categorized into three
stages: activation, proliferation, and differentiation. These stages of
B cell development have been viewed as sequential events, initiated
and regulated by distinct and specific signals (Dutton and Swain,
1987; Jelinek and Lipsky, 1987). Classically, B cell responses induced
by various stimuli have been differentiated as either T cell
independent (TI) or T cell dependent (TD) based on their apparent
requirement for T cell factors to support the differentiation into
antibody-forming cells. Today, this sequence of events is no longer
so clearly defined. Recent studies suggest a variety of T cell derived
lymphokines may be involved in each step of the B cell response,
including preparing small resting B cells to respond before
interaction of surface Ig receptors (Oliver et al., 1985; Rabin et al.,
1985). B cell responses may then vary only in the degree of T cell
help required. Thus, each stage of the B cell response will be
discussed in terms of the effects of the classically defined TI and TD
antigens, rather than the categorical TI versus TD response.
Salmonid B cell ontogeny. In the teleost, the sites of
lymphohematopoeitic activity include the kidney, thymus and
spleen. In addition to these organs, lymphocytes can be found in the
peripheral blood, gut-associated lymphoid tissue (GALT), and in the3
lymphatic vessels that are differentiated from the vascular system
(Zapata and Cooper, 1990; Pontius and Ambrosius, 1972).
During ontogenetical development, the thymus has been
shown to precede the spleen and kidney in the appearance of
lymphocytes, though hematopoeitic stem cells are already
identifiable in the kidney well before the onset of lymphoid
differentiation in the thymus (Ellis, 1977; Grace and Manning, 1980;
Zapata, 1981). The thymus exists as a pair of lobes, one located on
each side of the gill cavity (Chilmonczyk, 1983), and is believed to
consist of thymic lymphocytes in varying degrees of maturation, in
addition to some erythrocytes and macrophages (Yasutake and
Wales, 1983).
Though differentiated lymphocytes may first appear in the
thymus, it is currently believed that the anterior kidney is the
primary hematopoietic organ in the teleost, and has been compared
to mammalian bone marrow in function (Zapata, 1979; Irwin and
Kaattari, 1986; Zapata and Cooper, 1990). Every line of
hematopoietic differentiation has been observed in the kidney
including the hypothetically pluripotent stem cells, as well as
immature and mature red and white blood cells (Smith et al., 1970;
Zapata, 1979; Al-Adhami and Kunz, 1976). The kidney can be
divided into two distinct segments, an anterior and a posterior
segment (Ellis and de Sousa, 1974; Zapata, 1979). The primary site
of hematopoiesis is found in the anterior quarter of the kidney
which contains lymphatic vessels and opens into the coelomic cavity.
Alternately, the spleen is suggested not to be essential for
immunological maturation and in most fish serves as an accessory
hematopoietic organ. This has been evidenced by the studies
demonstrating that kidney and thymus lymphocytes display surface
immunoglobulin and respond in a mixed lymphocyte reaction even
when the spleen is present only in an immature form (Ellis, 1977;
Tamer and Manning, 1983; Yasutake and Wales, 1983). Additionally,
the spleen when compared to the anterior kidney has been shown to
harbor B cells comprised of a different repertoire than those found
in the anterior kidney (Kaattari and Irwin, 1985). Splenic lymphoid4
tissue is also not highly developed in teleosts. It differs from the
mammalian spleen in that the red and white pulps are diffuse and
connective tissue is not prominent (Robertson and Wexler, 1960;
Anderson, 1974).
Salmonid B cell response. Phylogenetic studies generally agree that
the earliest manifestations of immunoglobulins and antibody
function is seen in fish (McKinney et al., 1977; Sima and Vetvicka,
1990). Initial assessment of a teleost humoral immune response in
vitro can probably be attributed to Smith et al., 1967. Using a
modification of the hemolytic plaque assay, cells producing
hemolytic antibody were found in two organs, the spleen and the
pronephros in the bluegill, Lapomis macrochirus. Using similar
techniques, immunocompetent cells were later found in the spleen
and anterior kidney of the rainbow trout, Salmo gairdneri (Chiller et
al., 1969a; Chiller et al., 1969b; Pontius and Ambrosius, 1971). These
studies demonstrated both antigen binding and antibody producing
cells could be found in these organs. The ability to produce
antibodies led to the conclusion that these fish possessed cells equal
in at least one function to the B lymphocytes of mammals. But early
studies conducted by many investigators could not distinguish if B
lymphocytes in fish were specialized and therefore separate from T
cells (or cells with T-like functions) or if B lymphocytes were
multifunctional and served in both capacities as B and T cell
combined.
What confused some early studies was the fact that the
methods employed to identify B and T cells used polyclonal antisera
raised against fish immunoglobulin. These antisera, being polyclonal,
invariably reacted with all fish lymphocytes and thus was
ultimately useless (Clem et al., 1991). In contrast, rosette formation
and nylon wool filtration were used with some success to separate
two distinct types of mitogen-reactive, antigen-binding cells
(Cuchens and Clem, 1977; Ruben et al., 1977).5
Accessory Cells and the Immune Response
Immune responses in ectothermic vertebrates are attributable
to cell-cell interactions similar to those seen in higher vertebrates
(reviewed by Vallejo et al., 1992). In both channel catfish and
rainbow trout, unequivocal evidence exists to document the
hypothesis that counterparts of mammalian T and Ircells are
distinct lymphocyte populations defined both in terms of phenotype
and function (reviewed by Kaattari, 1992; Chilmonczyk, 1992). In
mammals, the induction of antigen-specific immune responses
requires yet another set of cells, loosely referred to as accessory
cells, which include blood monocytes, tissue and exudate
macrophages (Unanue, 1984; Papadimitriou and Ashman, 1989),
dendritic cells (Me lief, 1989), and epidermal Langerhans cells
(Streilein and Grammer, 1989). These cells provide the machinery
for antigen processing and contain major histocompatability (MHC)
molecules required for the presentation of processed antigen to
specific lymphocytes (Unanue, 1984; Chesnut and Grey, 1985), thus
they are also referred to as antigen-presenting cells (APC). This
particular accessory function is also accomplished by B cells, and to
a certain extent T cells (van Rooijen, 1990; Harding, 1991). Second,
they also provide growth factors (such as interleukin 1 [IL-1]) which
are necessary costimulatory signals for T cell activation (Weaver
and Unanue, 1990). In this regard, rainbow trout and catfish
monocytes (or macrophages) as well as several other lower
vertebrate species have been found to secrete a soluble factor akin
to IL-1 (Ortega and Kaattari, 1993a; Vallejo et al., 1991). In fact, the
requirement for trout monocytes or macrophages for the induction
of either lymphocyte mitogenesis or anti-hapten plaque-forming cell
(PFC) responses in vitro can be substituted by the addition of
exogenous trout IL-1, similar to the situation observed in both
catfish and mammalian systems. Reports by Vallejo and coworkers
(Vallejo et al., 1990; Vallejo et al., 1991) suggest that eitheraccessory cells other than monocytes or macrophages, i.e. B cells, are
involved in processing and presentation; alternatively, processing
and presentation of TD antigens are not required in the generation
of catfish immune responses. The results of studies addressing this
issue are discussed below.
Antigen trapping: in vivo studies. The hypothesis that antigen
nonspecific cells participate in the induction of ectothermic
vertebrate specific immune responses originally stemmed from
studies on antigen retention in different tissues and organs. Early
work by Kroese and colleagues (Kroese, 1983; Kroese et al., 1985)
and White et al. (1975) invariably demonstrated that a wide variety
of foreign substances (antigens such as soluble proteins, bacterins,
and preformed immune complexes) were "trapped" in the spleen
and other peripheral lymphoid organs of various vertebrate species.
Histological and ultrastructural analysis showed that such trapped
substances were consistently found associated with phagocytes
(macrophages) within lymphoid organs (Ellis et al., 1976; Ellis,
1980). Similar observations were reported for different fish species
(Secombes et al., 1982; Lamers and de Haas, 1985; Ziegenfuss and
Wolke, 1991). It appears that phagocytic cells, particularly those in
the spleen and pronephros, form discrete aggregates that increase in
both size and number subsequent to administration of antigen
(Zapata et al., 1987). It has been repeatedly demonstrated by
researchers that regardless of tissue or organ location, such
phagocytes are situated in the vicinity of populations of
lymphocytes (Secombes et al., 1982; Lamers and de Haas, 1985),
leading to the suggestion that these phagocytes are reservoirs of
antigen and are involved in antigen presentation for the induction of
specific antibody responses in vivo (Miller et al., 1987; Rombout et
al., 1989).
While such a hypothesis is plausible, localization of antigen
within phagocytes of lymphoid or hematopoietic organs in itself
does not prove that such organs or cells are antigen reservoirs. For
example, Szakal et al. (1983) have reported that murine7
macrophages in the subcapsular and medullary sinuses of lymphoid
tissues actually transport ingested antigen from the afferent to the
efferent side of the organ for clearance. Moreover, early studies
using both mammals (Nilsson and Berg, 1977) and fish (Smedsrud et
al., 1984) have shown that considerably large proportions of
antigens are localized in the liver and the excretory tissues of the
kidneys suggesting active clearance or eliminationof the foreign
materials. Furthermore, Blazer et al. (1987) and Ziegenfuss and
Wolke (1991) have reported that accumulations of 13-articulate
materials in piscine livers were found among macrophage
aggregates similar to those observed in the spleen and kidneys.
Although such antigen-trapping may result in the production of
detectable quantities of specific serum or mucosal antibodies
(Rombout et al., 1989), the exact role of tissue macrophages in
antibody production cannot be determined solely by the use of such
descriptive studies.
The existence of antigen accumulation in vivo has been
demonstrated in the mouse by Szakal et al. (1988). Following
antigen exposure, follicular dendritic cells in peripheral lymph
nodes developed a "beaded" morphology. Immunocytochemical and
ultrastructural analyses revealed that these "beads" contained
antigen and persisted for long periods of time (up to 14 days). These
beads were slowly released and dispersed into the surrounding
microenvironment where germinal center B cells and resident
macrophages were found to endocytose them (Szakal et al., 1988).
The function of these putative antigen reservoirs was confirmed by
Tew et al. (1988) with the demonstration that these bead-containing
B cells and macrophages served as APC for the stimulation of IL-2
production by antigen-specific T cells in vitro. Further, it was
demonstrated that murine macrophages can transfer processed
antigen to B cells, which in turn present antigen to specific T cells.
Antigen uptake and catabolism: in vitro studies. Phagocytes,
particularly macrophages, are actively involved in antigen clearance
regardless of species; these cells are clearly among the first lines of8
defense against infection (reviewed by Papadimitriou and Ashman,
1989). Without antigen uptake and processing immune responses
would most likely be limited due to a decreased exposure to
recognizable antigens. Definitive studies pertaining to the
mechanisms of piscine phagocytosis, intracellular killing, and
catabolism have been reported (reviewed by Secombes and Fletcher,
1992). Such studies were facilitated by the relative ease of isolation
of fish macrophages and monocytes as reported by Miller and
coworkers (Miller et al., 1985; Miller et al., 1986).
Direct correlation between antigen uptake and degradation by
fish macrophages and subsequent induction of antigen-specific
immune responses has yet only been unequivocally demonstrated in
catfish by Vallejo and coworkers (Vallejo et al., 1990; Vallejo et al.,
1991). These researchers have shown that uptake of exogenous
protein antigens by freshly isolated catfish peripheral blood
monocytes (fibronectin-adherent, nonspecific esterase positive cells)
or long term cultures of such cells was subsequently followed by
intracellular proteolysis. In addition, antigen uptake and
degradation by monocytes were observed even at low temperature
regimes previously reported to induce suppression of primary
catfish T cell responses (Miller and Clem, 1984; Bly and Clem, 1991).
Vallejo and coworkers (Vallejo et al., 1990) also report that
following exposure to antigen, cells may be used as APC for the
induction of antigen-specific immune responses in vitro by
autologous immune lymphocytes. These findings indicate that
catfish monocytes do not simply degrade antigens for the purpose of
elimination, but that such metabolic activities result in the exposure
of antigen determinants that are stimulatory to specific
lymphocytes. Clearly, these observations support the idea that
accessory cells are required for the generation of fish immune
responses as previously reported by Miller, Clem and coworkers
(Miller et al., 1985; Clem et al., 1985).
Antigen presentation. To further elucidate the role of accessory
cells in fish immune responses, Clem and coworkers (Miller and9
Clem, 1984; Vallejo et al., 1990) have reported observations which
suggest that antigen presentation occurs and macrophages perform
this function (Vallejo et al., 1991). Initial strategies utilized immune
peripheral blood leukocytes (PBL) both as accessory cells and
responders for the induction of secondary antigen-specific immune
responses in vitro (Vallejo et al., 1990). Catfish PBL previously
primed in vivo with antigen were pulsed with homologous antigen
in vitro, washed, fixed with paraformaldehyde, and then co-cultured
with freshly isolated autologous immune PBL. Antigen-pulsing of
the putative APC allowed for antigen uptake and intracellular
processing as observed in mammalian accessory cells (reviewed by
Chain et al., 1988; Yewdell and Bennick, 1990). Therefore it was
suggested by the authors that any antigen-specific immune
responses elicited by autologous PBL responders were attributed to
antigen which became APC-associated during antigen-pulsing.
Furthermore, fixation of the putative APC ensured that such cells
did not proliferate in culture and prevented further processing of
antigen. The results of this study showed that immune PBL
responders underwent antigen-specific proliferation and antibody
production when cocultured with antigen-pulsed and fixed APC
similar to control PBL cultures directly stimulated with soluble
homologous antigen (Vallejo et al., 1990). These in vitro responses
were abrogated by fixation of putative APC prior to antigen-pulsing.
The advent of cell separation protocols has permitted the
identification of many immune cell functions in both mammalian
and piscine systems, including the identification of the APC. Studies
with catfish immune cells using similar antigen-pulsing strategies
(with unfractionated PBL used as APC) showed that both monocytes
and B cells are efficient APC (Vallejo et al., 1991). It should be noted
that previous studies (Smith and Braun-Nesje, 1982; Sizemore et al.,
1984; Graham and Secombes, 1990) have determined that the
number of macrophages necessary to give optimal responses in vitro
is in the order of 1-8% of the responding population, with larger
numbers of macrophages resulting in no further significant effect.
Antigen-pulsed and fixed T cells also stimulated the proliferation of10
autologous PBL responders, although the magnitude of the responses
was considerably lower (approximately 10% of the maximum
response) than those elicited with either monocytes or B cells
(Vallejo et al., 1991). The finding that catfish T cells have weak APC
capacity was not particularly suprising. In mammals, T. cells may
express MHC molecules, the self-determinants responsible for
antigen presentation and immune restriction. Such MHC-expressing
T cells have been shown by Reske-Kunz et al. (1986) to be effective
APC. Although the exact role of MHC (or MHC-like) Molecules in
antigen presentation in piscine systems has yet to be elucidated, the
apparent restrictions of catfish immune responses discussed above
suggest that piscine T cells may be viable APC, albeit less efficient
than either monocytes or B cells.
Cell separation techniques have also been used to determine
the accessory cell-derived requirements of a number of other
piscine immune responses. In Atlantic salmon and catfish, such
experiments have shown that T cell mitogen and mixed leukocyte
reaction (MLR) responses are dependent upon the presence of
macrophages (Smith and Braun-Nesje, 1982; Sizemore et al., 1984;
Miller et al., 1986). Similarly, catfish APC responses to TD and TI
antigens are accessory cell dependent (Miller et al., 1985), as is
lymphokine (macrophage activating factor) production by surface Ig
negative (slg -) lymphocytes in rainbow trout (Graham and
Secombes, 1985). Ellsaesser et al. (1988) have shown that a
naturally occurring accessory cell depleted lymphocyte population
appears to be present in the catfish thymus, where isolated
thymocytes are unable to proliferate in vitro in response to Con A
unless monocytes are added to the cultures. In an alternative
approach, Sizemore et al. (1984) have shown that inhibition of
macrophage function with 5mM L-leucine methylester markedly
decreases the mitogenic response of unfractioned leukocytes to Con
A. These responses can be restored by adding untreated
macrophages from the same individual, confirming the selectivity of
the effect. To date, only the mitogen responsiveness of slg+11
lymphocytes has been shown to be macrophage-independent
(Sizemore et al., 1984).
Indications that accessory cell function may be genetically
restricted have been presented by Vallejo et al. (1990) by using
allogeneic leukocytes as antigen presenting cells. Although able to
stimulate a proliferative (MLR) response, antigen-pulsed allogeneic
cells cannot induce an antibody response from in vivo primed cells.
It has been reported, however, that on the rare occasions when two
way MLR negative pairs of fish have been found (indicative of small
or no MHC differences), mixing allogeneic cells does allow antibody
responses to occur with homologous cells (Clem et al., 1991).
Cellular pathways of antigen processing and presentation. Studies
with mammalian models have revealed that antigen processing
involves a complex series of normal cellular and biochemical events
that result in the exposure of epitopes that are otherwise buried in
the native conformation of an antigen (reviewed by Chain et al.,
1988). Such events may involve simple unfolding, denaturation, and
partial or complete proteolysis, and may occur either intracellularly
or on the plasma membrane of accessory cells (Harding et al., 1988;
Chain et al., 1988; Semple et al., 1989). Regardless of the mode and
site of processing, antigens become structurally modified to a
particular conformation capable of binding MHC molecules (Harding
et al., 1990). This latter bimolecular complex is re-expressed on the
surface of accessory cells and presented to specific T cells (Braciale
et al., 1987). In mammals, there are two pathways of antigen
processing that are closely tied to the two classes of MHC molecules
and the two T cell subsets (Harding, 1991). There is the endogenous
or cytosolic pathway and the exogenous or endocytic pathway. In
the exogenous pathway, antigens are endocytosed by the APC from
its environment. Antigens are then processed intracellularly in an
acidic endocytic compartment and subsequently intersect with
endosomes containing Class II MHC molecules en route to the plasma
membrane (Jensen, 1990). Harding et al. (1990) have shown that
the acidic environment of the endosome may facilitate the12
interaction of MHC with the appropriate processed antigen or
immunogenic peptides.
In contrast, the endogenous pathway is primarily tied to Class
I MHC binding of antigens (Harding, 1991). It is commonly accepted
that cytotoxic T cells (i.e. CD8+ cells) are able to recognize their
targets by this pathway. In this case, APC synthesize the antigens,
which are mostly tumor and viral proteins. It has been reported by
Yewdell and Bennick (1989) that such antigens are then targeted to
endosomes where they undergo processing subsequently leading to
the interaction of immunogenic peptides with Class I MHC molecules.
Although there is clear dichotomy of processing pathways of
antigens and their presentation by two classes of MHC molecules,
they are by no means absolute. Several studies reveal that
exogenous antigens may also be presented by Class I MHC molecules
and conversely, endogenous antigens may also be presented by
Class II MHC molecules (Nuchtern et al., 1990; Rock et al., 1990). The
factors that determine which class of mammalian MHC molecules the
"processed" antigen binds are not known, although there is recent
evidence that the invariant chain of Class I might have such a role
(Teyton et al., 1990).
The results of recent piscine studies on antigen processing and
presentation in the channel catfish reported by Vallejo and
coworkers exhibit hallmarks of the exogenous pathway (Vallejo et
al., 1990; Vallejo et al., 1992). Clearly, catfish APC take up a variety
of exogenous protein antigens which are then subjected to
intracellular degradation. Moreover, the observation that antigen-
pulsing of viable, but not pre-fixed, APC results in the formation of
peptide fragments of both complex and simple TD antigens (Vallejo
et al., 1991) certainly indicates that antigen processing is a
necessary step in the immunological recognition of foreign antigens
in fish. Finally, the importance of intracellular proteases is also
demonstrated by the finding that catfish APC functions are also
blocked in the presence of protease inhibitors during antigen-
pulsing (Vallejo et al., 1991).13
Production of cytokines with accessory activity. Another critical
aspect of accessory cell function is the elaboration of cytokines
which mediate immune cell interactions. Particularly important are
those cytokines which mediate natural immunity, and those which
regulate lymphocyte activation, growth, and differentiation. The
cytokines involved in these processes are the interferons,
interleuldn-1 (IL-1),and interleukin-2 (IL-2). The role of these
cytokines in both mammalian and piscine immune responses are
introduced and discussed below.14
Cytokines and the Immune Response
The immunological literature of the 1960s and 1.970s is
replete with descriptions of different in vitro biological activities of
"factors" (cytokines) in culture supernatants of antigen- and
mitogen-stimulated leukocytes. Such investigations resulted in a
veritable alphabet soup of acronyms to describe the-diverse effects
of these leukocyte-derived factors on the in vitro activities of
leukocytes (such as Macrophage Inhibition Factor [MIF], Macrophage
Activating Factor [MAF], and Lymphocyte Activating Factor [LAF])
(Dumonde et al., 1969; Neta et al., 1990). It was not until
recombinant DNA technology made it possible to produce large
quantities of the different cytokines that some order in
nomenclature was achieved and an understanding of cytokine
function was forthcoming. Currently, at least 16 different human
cytokines have been isolated, their primary structure determined,
their genes cloned, and their biological effects examined (reviewed
by Neta et al., 1990). It is now known that effective communication
among leukocytes during the course of an immune or inflammatory
response depends on these low molecular weight (Mw) polypeptide
cytokines. It is now well accepted that cytokines are involved in
regulating the size and duration of immune and inflammatory
responses, are produced both transiently and locally, and can act in
a paracrine, autocrine, and possibly an endocrine fashion. Previous
studies (reviewed by Neta et al., 1990) have revealed considerable
duplication of in vitro biological activity by biochemically and
genetically distinct cytokine molecules. These studies have also
pointed out that cytokines interact in a network in which one
cytokine can induce or inhibit the production of another, as well as
modulate the action of other cytokines on the same target cell.
Cytokines produced predominantly by cells of the
macrophage/monocyte lineage are termed monokines and include
the type 1 interferons (IFN) alpha and beta (Friedman and Vogel,15
1983), interleukin-1 (IL-1) (diGiovine and Duff, 1990; Dinarello,
1990), IL-6 (Kishimoto et al., 1990), tumor necrosis factor (TNF)
alpha (Beutler and Cerami, 1988), and the granulocyte and
monocyte colony-stimulating factors (G-CSF, M-CSF, GM-CSF) (Kelso
et al., 1990). Cytokines produced by lymphocytes are termed
lymphokines and include transforming growth factor beta (TGFB)
(Derynck et al., 1985), IFN gamma (Trinchieri and Perussia, 1985),
IL-2 (Smith, 1984), IL-3 (Schrader, 1986), IL-4 (Paul and Ohara,
1987), IL-5 (Kinashi et al., 1986), IL-7 (Namen et al.,-1988), and
lymphotoxin (TNF beta) (Paul and Rudd le, 1988).
The vast majority of the past and current cytokine literature is
devoted exclusively to cytokines of human or murine origin that are
assayed in systems involving human or murine cells and tissues.
Most of the remaining cytokine literature involves other mammalian
species. There are, however, studies that address the issue of
whether leukocytes of nonmammalian vertebrates also produce
cytokines. This review will focus on those regulatory cytokines
which have provisionally been identified in teleost species as
interferons, IL-1, and IL-2, by virtue of their biochemical and
functional similarities to those molecules in mammals. In this
review only mammalian and piscine cytokines will be addressed.
Interferons in mammalian immune systems. Interferons were
originally defined by their ability to inhibit virus replication
(Wheelock, 1965; Trinchieri and Perussia, 1985). In mammals, three
major classes of interferon have been described: IFN alpha, beta,
and gamma (reviewed by Stewart, 1980; Farrar and Schreiber,
1993). IFN alpha and beta are sometimes grouped together as type I
interferons. Molecular cloning of these interferons has revealed
more than 25 subtypes of IFN alpha and 2 of IFN beta (Henco et al.,
1985; DeGrado et al., 1991).
Both IFN alpha and beta are produced by a variety of cell
types including macrophages, endothelial and epithelial cells, and
lymphocytes (Pestka et al., 1987). However, IFN alpha and beta are
produced predominantly by macrophages and fibroblasts,16
respectively (Stewart, 1980). Taniguchi et al. (1980) have reported a
45% nucleotide sequence identity between cloned human IFN alpha
and beta genes, suggesting they could have originated from a
common ancestral gene several hundred million years ago.
Divergence may have occurred after the appearance of bony fish,
since no cross-hybridization occurs between human IFN alpha cDNA
and fish DNA, although weak hybridization with human IFN beta
does occur (Wilson et al., 1983).
Type I interferons have a variety of in vitro and in vivo
effects in addition to their antiviral activities. In vitro, type I
interferons inhibit cell proliferation, tumor growth, and fibroblast
differentiation, as well as stimulate macrophages accessory activity
and cytokine production (reviewed by Rhodes et al., 1986). In vivo,
type I interferons can modulate antibody production, delayed
hypersensitivity reactions, and induce inflammatory reactions
(Farrar and Schreiber, 1993).
IFN gamma, the product of antigen or mitogen activated T cells
and natural killer (NK) cells (Kasahara et al., 1983; Munakata et al.,
1985), is unrelated to type I interferons; IFN gamma displays less
than 10% amino acid sequence identity with IFN alpha or beta
(Taniguchi et al., 1980; Gray and Goeddel, 1982; Gray and Goeddel,
1983). Nevertheless, like type I interferons IFN gamma modulates
macrophage functions by activating macrophage oxidative
metabolism and antimicrobial activity(Schreiber et al., 1983). IFN
gamma can also upregulate expression of class I and II MHC
antigens on a variety of cell types (reviewed by Inaba et al., 1986).
Interleukin -1 in mammalian immune systems. Originally named
Lymphocyte Activating Factor (LAF), interleukin 1 (IL-1) is often
also called by many other names which describe this factor's
different reported activities (reviewed by Neta et al., 1990).
Two forms of IL-1 have been isolated: IL-1 alpha (Gubler et
al., 1986) and IL-1 beta (Matsushima et al., 1986). Both of these
polypeptides have been found in human, rabbit (Furutani et al.,
1985), and mouse (Gray et al., 1986) and exhibit significant17
interspecies homology at the amino acid level (62% homology
between human and mouse IL-1 alpha: Gray et al., 1986). Mature
IL-1 alpha and IL-1 beta are both polypeptides with molecular
weights of about 171(D (Dinarello, 1985; March et al., 1985). The
significant variation observed in the literature presumably is due to
the heterogenity of glycosylation of both forms. Perhaps the most
distinguishing characteristic of these two peptides is their isoelectric
points (pI): the pI of IL-1 alpha is 5.0 whereas the pI of IL-1 beta is
7.0 (Ihrie and Wood, 1985; Matsushima et al., 1986). Although
neither IL-1 alpha nor beta display strict species specificity, the
intensity of biological responses appears to be species specific
(Ellsaesser, 1989; Simon and Lee, 1986).
IL-1 alpha and beta represent the products of two distinct
genes and are each initially synthesized as 30-32kD precursor
peptides of 270 and 269 amino acids, respectively (Hazuda et al.,
1991). Mature forms of IL-1 alpha and beta are represented by C-
terminal cleavage products of 159 and 153 amino acids, respectively
(March et al., 1985). Tocci and collegues (Tocci et al., 1985; Cameron
et al. 1985) have demonstrated that both IL-1 precursors lack a
hydrophobic signal peptide thought to be required for the
extracellular transport of proteins manufactured within the cell.
Recent evidence reported by Beuscher and collegues (Beuscher et al.,
1988; Beuscher and Cohen, 1988) suggests that phosphorylation of
human and mouse IL-1 alpha precursors may play a role in
processing and transport via a lysosomal pathway. Biochemical data
reported by Zola et al. (1993) demonstrate the existence of a
membrane bound form of IL-1 alpha. However, the mechanism of
IL-1 cell secretion is still largely unknown.
An inhibitor of IL-1 has recently been identified (Arend,
1991; Conti et al., 1992a). This molecule, termed IL-1 receptor
antagonist (IL -ira), binds to the IL-1 receptor with similar affinities
as IL-1, but has no IL-1-like activity even at high concentrations,
thus accounting for its antagonistic properties (Conti et al., 1992c).
The purified molecule has a molecular weight of approximately 18-
22kD, compared with a predicited molecular weight of 18kD from18
cloning data (Arend, 1991). It is believed that glycosylation patterns
account for the differences in molecular weight. IL-lra appears to
be produced by the same cells which produce IL-1 alpha and beta
(Re et al., 1993; Andersson et al, 1992). It has limited sequence
similarity at the amino acid level to IL-1 alpha (19%) and beta (26%)
(Conti et al., 1992b). IL-lra is induced in monocytes by IgG, LPS,
PMA, and zymosan A (Re et al., 1993). Unlike IL-1 alpha or beta, IL-
ira appears to be species-specific in its binding to the IL-1 receptor
(Hannum et al., 1990).
IL-1 alpha and beta exert their effects by binding to two
distinct receptor types (Spriggs et al., 1992). The type I IL-1
receptor is an 80kD protein (Chizzonite et al., 1989; Bomsztyk et al.,
1989) and is a member of the Ig superfamily of receptors,
possessing three extracellular Ig-like domains, a short
transmembrane domain, and a relatively large cytoplasmic domain
(Spriggs et al., 1992). Both human and murine versions of this
receptor have been identified and exhibit similar characteristics in
terms of affinity for IL-1 and receptor number (Bomsztyk et al.,
1989). Sequence information obtained for the human IL-1 receptor
type I reported by Spriggs et al. (1992) indicates a 69% amino acid
homology between the human and murine forms of this receptor.
A second IL-1 binding protein, called IL-1 type II receptor
has also been cloned (McMahan et al., 1991). This protein, also a
member of the Ig superfamily, has an extracellular ligand-binding
domain composed of three Ig-like domains, a single transmembrane
domain, and a short cytoplasmic domain of 29 amino acids in
contrast to a large 215 amino acid cytoplasmic domain of the type I
IL-1 receptor (McMahan et al., 1991). Its predicted molecular
weight from the cloned cDNA is approximately 44kD, compared with
the molecular weight of the purified protein of 60-68kD.
Glycosylation at several residues probably account for these
differences (Mancilla et al., 1992). The type II receptor is expressed
on a number of different tissues, including both T and B cells,
monocytes, granulocytes, macrophages, and neutrophils (Spriggs et
al., 1992). IL-1 type II receptor also binds to IL-1 alpha, beta, and19
IL -ira with different affinities as compared with the type I receptor
(McMahan et al., 1991).
Both human and murine receptors appear to signal via
activation of a phosphorylation cascade, although both lack intrinsic
kinase activity (McMahan et al., 1991). Portions of the cytoplasmic
domain of the receptor seem to share sequence similarities with
known nucleotide binding proteins, suggesting that IL-1 dependent
signals may involve an intrinsic receptor G protein-like activity
(McMahan et al., 1991). IL-1 has been shown to increase
phospholipase A2 activity and the release of linoleic acid from
certain T cells (Bomalski et al., 1992). Weitzman and Savage (1992)
have reported observations indicating IL-1 receptor complexes
associated with the nucleus following incubation of target cells with
IL-1. IL-1 receptor activation also activates both the AP-1 and NF-
kB transcription factors (Iwasaki et al., 1992).
A number of cell types have been shown to produce IL-1,
including monocyte and macrophage cell lines, natural killer cells
(NK), B cell lines, B lymphoblasts, endothelial cells, melanoma cell
lines, neutrophils, fibroblasts, epithelial cells, adult T cell leukemic
cell lines, and certain murine T cell lines (reviewed by Dinarello,
1990). Some reported IL-1 activities include (reviewed by Radeke
et al., 1991):
1. Activation of T cells in the presence of co-stimulation
through the T cell receptor (Mizuochi et al., 1988).
2. Induction of IL-2 receptor expression and cytokine gene
expression (Lowenthal et al., 1986; Conti et al., 1992b).
3. Co-stimulation of thymocyte proliferation (Herbelin et al.,
1992).
4. Stimulation of pre-B cell differentiation (Oka and Ito, 1987).
5. Co-stimulation of B cell proliferation and Ig secretion
(Bonnefoy et al., 1989).
6. Augmentation of IL-2 and IFN-induced activation of NK-
mediated cytotoxicity (Marumo et al., 1992).
7. Modulation of reparative functions following tissue injury
(Neta et al., 1991; Kessler et al., 1992).20
8. Induction of acute phase protein synthesis by hepatocytes
(Brevario et al., 1992).
It has also been shown that IL-1 stimulates the release of
factors associated with the growth and differentiation of cells from
myeloid and lymphoid lineages in vitro (Zoja et al., 1992; Streiter et
al., 1992; Herbelin et al., 1992). Fibbe et al. (1988) have reported
that IL-1 may induce the production of macrophage colony
stimulating factor by human bone marrow stromal cells.
Granulocyte-macrophage colony stimulating factor from both human
fibroblasts and peripheral blood lymphocytes have also been shown
to be induced by IL-1 (Fibbe et al., 1988; Allen et al., 1992). IL-1
also stimulates hematopoiesis by upregulating receptors for colony
stimulating factors and inducing the proliferation of pluripotent
progenitors in the bone marrow (Hestdal et al., 1992).
Interleukin -2 in mammalian immune systems. IL-2 was the first of
a series of T-helper cell-derived lymphokines to be described and
completely characterized at the protein (Robb et al., 1983; Welte et
al., 1982) and nucleotide level (Holbrook et al., 1984). IL-2
(formerly called T Cell Growth Factor [TCGF]) plays a key role in
antigen-specific clonal proliferation of T cells (reviewed by Smith,
1988; Sabath and Prystowsky, 1990). IL-2 also acts on activated B
cells to induce growth and secretion of immunoglobulin (Harada et
al., 1987; Nakanishi et al., 1987). IL-2 can also evoke superoxide
production by activated macrophages (Holter et al., 1987), as well as
increase killing activity of NK cells (Zarcone et al., 1987).
Administration of purified IL-2 to humans in clinical trials has been
shown induce a rise in plasma ACTH and cortisol, supporting the
notion that IL-2 has hypothalamo-pituitary-adrenal axis activity in
vivo (Lotze et al., 1985).
Human IL-2 isolated from cell culture supernatants has been
shown to have a Mw of 19-22kD by gel filtration chromatography
and 14-16kD as determined by SDS-PAGE (Robb and Greene, 1983).
Cloning data obtained from IL-2 cDNA sequence suggest that IL-2 is
originally translated as a 153 amino acid polypeptide (Taniguchi et21
al., 1983; Nikaido et al., 1984). Cleavage of the 20 residue leader
peptide sequence yields a 133 amino acid protein with a predicted
Mw of 15.4kD (Taniguchi et al., 1983).
IL-2 exerts its effects through a specific, saturable receptor
system found primarily on T cells, B cells, and NK cells. The IL-2
receptor is a multi-subunit system consisting of a 55kD alpha
subunit (Tac antigen) and a 70kD beta subunit (Robb et al., 1984).
Whereas the beta subunit is expressed on resting T cells, alpha
subunit expression must be induced by mitogenic stimulation
(Holter et al., 1987). A soluble form of IL-2 receptor has been
identified by Kuo and collegues which is released by mitogen- or
antigen-activated T cells (Kuo and Robb, 1986; Kuo et al., 1986). The
N-terminal 192 amino acids of the membrane-bound alpha subunit
is released by proteolytic cleavage from the T cell surface to form
the 45kD soluble IL-2R (Neeper et al., 1987; Taniguchi et al., 1990).
IL-2 is produced by T cells in response to activation by
mitogens, alloantigens or antigens presented in context with the
appropriate MHC molecules (Tigges et al., 1989). Perhaps the most
important effect of IL-2 is the autocrine or paracrine stimulation of
T cells expressing IL-2 receptors reported by Taniguchi et al.
(1990). Briefly, it is believed that T cell activation fits a competence
and progression model. Competence is first conferred by stimulation
of T cells via the T cell antigen receptor, which in the presence of
other accessory signals (such as IL-1), promotes entry into the G1
phase of the cell cycle. Progression then follows and is dependent
upon the expression of IL-2 and IL-2 receptor alpha subunit
interaction of IL-2 with its receptor and the expression of other
gene products required for entry into S phase (Tigges et al., 1989).
In addition to its well known effects on T cell growth, IL-2 has
been shown to augment B cell growth and immunoglobulin
production (Harada et al., 1987), augment interferon gamma
production (Smith, 1988), induce IL-6 production by human
monocytes (Kishimoto et al., 1987), and modulate the expression of
the IL-2 receptor (Harada et al. 1987).22
Interferons in piscine immune systems. Owing to the antiviral
activities of the mammalian interferons and a number of known
viral diseases of commercially important species of fish, there is
substantial literature reflecting the search for interferon-like
cytokines in teleosts (Okamoto et al., 1983). In some studies,
antiviral activity was induced by the parenteral administration of
pathogenic viruses and assayed by measuring the nonspecific
protective effects of serum either in vitro on virus-infected fish cells
(deKinkelin et al., 1982) and/or in vivo by passive transfer of the
same serum from which antiviral antibodies had been removed
(Desena and Rio, 1975). Characterization of partially purified serum
components revealed that the molecules conferring antiviral activity
had an apparent Mw from 24 to 94 kD with isoelectric focusing (IEF)
points from 5.4 to 7.1 (Desena and Rio, 1975). These antiviral serum
components appeared to be type I interferons by virtue of their
temperature and acid stability.
Recently, better resolution of the factor(s) displaying IFN-like
activity in fish has been provided by the sytematic studies of
Graham and Secombes (1988). Culture of rainbow trout peripheral
blood and head kidney leukocytes that had been pulsed for 3 hours
with Con A resulted in increased spreading and adherence of
macrophages (Secombes, 1987). Such experiments produced culture
supernatants which contained apparent MAF activity in that they
increased the respiratory burst (superoxide production) and
bactericidal activity of either resident or elicited macrophages
(Secombes, 1987). Greater MAF activity occurred when leukocytes
were incubated with phorbol 12-myristate-13-acetate (PMA)
together with Con A (Graham and Secombes, 1990a). In a recent
study, Graham and Secombes (1990b) used cell adherence and
panning cell purification procedures to demonstrate that
supernatants from cultures of phorbol ester/lectin pulsed "pure"
macrophages or extensively purified surface Ig+ (B) cells lacked
MAF activity. In contrast, significant MAF activity was present in
supernatants produced by stimulated sIg- (T) cells, providing that
macrophages were also present in the cultures.23
Interleukin-1 in piscine immune systems. In a series of in vitro
investigations, Clem, Miller, and colleagues have demonstrated that
in the channel catfish, monocytes are needed for antibody
production and Con A and antigen-induced stimulation of peripheral
blood leukocytes (PBLs) and thymocytes (Miller et al., 1986).
Recently, Ellsaesser (1989) and Clem et al. (1991) have provided
convincing evidence that 24 hour culture supernatants from LPS-
treated catfish monocytes can replace monocytes in in vitro
immunological assays. The cytokine(s) in these supernatants were
also active in a mouse thymocyte costimulation assay. Treatment of
the supernatants with polyclonal anti-human IL-1 alpha/beta
antibodies partially inhibited their activity (Ellsaesser, 1989).
Whether this incomplete inhibition means that other cytokines (such
as IL-6) are also present in these supernatants is unknown.
Supernatants from a mouse macrophage cell line, P388D1, but
not recombinant human or mouse IL-1, could also replace catfish
monocytes in fish anti-TNP-LPS antibody responses and in Con A-
induced proliferation assays of catfish monocyte-depleted
thymocytes or PBLs (Ellsaesser, 1989). It is not known if murine
supernatants can also replace monocytes in the in vitro responses of
catfish cells to thymus-dependent (TD) antigens.
Isoelectric focusing (IEF) of channel catfish monocyte
supernatants reported by Ellsaesser (1989) revealed two peaks of
activity in a costimulation assay with catfish cells, with isoelectric
focusing points (pls) of 5 and 8. When the IEF fractions were
assayed on mouse cells, three peaks of activity could be visualized
(pls of 3.5, 4.7, and 6.1). From these data Ellsaesser (1989)
suggested that different molecules in the catfish monocyte
supernatants were responsible for stimulating mouse IL-2 sensitive
cells and catfish PBLs.
Western blot analysis of crude supernatants from fish and
mouse cells, and of active fractions from gel filtration columns was
performed using polyclonal antisera to human IL-1 alpha, beta, or
mouse rIL-1 alpha (Ellsaesser, 1989). The supernatants as well as24
high Mw fractions contained a protein with an approximate Mw of
65kD that reacted with the antiserum to human IL-1 beta. These
same samples also contained a protein of approximately 70kD that
reacted with antiserum to human IL-1 alpha. Also present in the
supernatant and in the low Mw fractions were proteins with a Mw
of approximately 24kD and 14kD that reacted with anti-IL-1 alpha
and anti-IL-1 beta, respectively. Supernatants from mouse P338D1
cells showed four bands of reactivity with antiserum to mouse rIL-1
alpha. These bands were seen in the high Mw fractions with activity
for mouse cells.
In summary, catfish IL-1-like molecules include a low Mw
form with activity for mouse cells and a high Mw form which is
active on catfish cells. Within these two size classifications, there
also appear to be two antigenically distinct forms of IL-1: those that
react with antibodies to human IL-1 alpha and those that react with
antibodies to human IL-1 beta. Northern analysis using cDNA probes
for mouse rIL-1 alpha does not detect a RNA species large enough to
account for the high Mw form of catfish IL-1. However, Ellsaesser
(1989) points out that it is possible that a smaller IL-1 protein is
made in channel catfish that subsequently exists as a polymer, or is
covalently attached to another undetermined protein. This form of
IL-1 is necessary for stimulation of channel catfish cells, yet is
inactive on mouse cells. The monomer, or unassociated protein, is
active on mouse cells, but not catfish cells. IL-1 from P388D1 (a
mouse macrophage cell line) cells appears to be either noncovalently
bound together or to form mixed polymers with other proteins,
resulting in an active form (for fish cells) which elutes as a large
protein by gel filtration but dissociates into smaller components on
SDS-PAGE analysis.
Since Ellsaesser (1989) and Clem et al. (1991) reported that
only the high Mw mouse IL-1 was active on catfish cells, it is not
surprising that the lower molecular weight recombinant human or
mouse IL-1 were incapable of stimulating catfish cells. The
observation, however, is in apparent opposition to the observations
of Hamby and coworkers (Hamby et al., 1986; Sigel et al., 1986) who25
reported that a purified protein preparation of human IL-1 with a
Mw of 15kD did stimulate channel catfish at suboptimal
concentrations of Con A. However, the catfish leukocytes used in this
study included monocytes that themselves could have been a source
of endogenous IL-1 (Ellsaesser, 1989; Clem et al., 1991).
Interleukin-2 in piscine immune systems. PHA or alloantigen-
stimulated pronephric carp leukocytes produce factors in
supernatants that are mitogenic for mitogen or alloantigen-induced
putative T lymphoblasts, but not resting lymphocytes (Grondel and
Harmsen, 1984). This T cell growth activity was partially reduced
following adsorption of the supernatant with the mitogen-activated
blasts, but not with resting leukocytes. Caspi and Avtalion (1984)
have reported data which suggests that only activated cells express
receptors for carp TCGF. These researchers have shown that IL-2
rich supernatants from the mouse EL-4 cell line do not support
growth of the fish blasts. Clem et al. (1991) also report data which
indicate that culture supernatants from catfish T cell lines that are
costimulatory for catfish T and B cells do not appear to function in
mouse bioassays for IL-2 and IL-4. In addition, recombinant mouse
IL-2 and IL-4 do not exhibit in vitro functional activity on catfish
cells (Clem et al., 1991). However, Caspi and Avtalion (1984)
reported that fish T cell blasts and alloreactive MLR-induced fish T
cell lines do grow in cultures containing supernatants from either
Con A treated rat lymphocytes or PHA-pulsed human peripheral
blood cells. Partially purified human IL-2 did not support growth of
fish blasts as well as the crude supernatants from which the
mitogens had not been removed. Although the lectin concentrations
in these crude supernatants were submitogenic for carp
lymphocytes, they could have been costimulatory with IL-1 (in the
supernatants), thereby evoking the production of homologous IL-2
from the fish cell cultures. The effect of multiple cytokines, which
are frequently present in crude supernatants, in many biological
assays has yet to be determined in piscine studies.26
CHAPTER 2
Requisite signals for B cell antibody production to a T-
independent antigen.
Henry W. Ortega and Stephen L. Kaattari 1,2
Department of Microbiology and Laboratory for Fish Disease
Research
Oregon State University
Corvallis, OR 97331-3804
1 To whom correspondence should be addressed
2 Current address:
Department of Environmental Science
Virginia Institute of Marine Science
College of William and Mary
Gloucester Point, VA 2306227
Abstract
The ability of different subpopulations of rainbow trout (0.
mykiss) peripheral blood leukocytes to respond to the T-
independent antigen trinitrophenylated-lipopolysaccharide (TNP-
LPS) was assessed by using an in vitro passive hemolytic plaque
assay. It is demonstrated that macrophages are required for the
provision of accessory function during the antibody response to this
antigen. Establishment of this accessory function was demonstrated
by the fact that macrophages (adherent leukocytes) were able to
restore the capacity for antibody production to isolated lymphocytes
(non-adherent leukocytes). Furthermore, supernatants from
antigen-stimulated macrophages were sufficient to restore
lymphocyte function. Finally limiting dilution analysis (LDA)
confirmed this requisite role of the macrophage-derived factor,
revealed that the target of this factor(s) is the B cell precursor, and
suggests that there may be differential sensitivity of B cell
precursors to this factor. Based on the factor source, function, and
molecular weight it is suggested that IL-1 is the requisite accessory
factor.28
Introduction
Resolution of the precise cellular requirements for piscine B
cell induction is most easily obtained by in vitro analysis. Much of
the pioneering work in this area has been accomplished by Clem and
coworkers (1991) using the channel catfish (Ictalurus punctatus).
Cellular fractionation techniques are critical to the resolution of
functionally distinct yet cooperative leukocyte subpopulations.
Utilization of monoclonal antibodies has permitted the isolation of
both surface immunolglobulin positive (sig+) and negative (sIg-)
lymphocytes (DeLuca et al., 1983). Together with specific procedures
for the removal or isolation of adherent cells (Secombes, 1990),
these techniques have been used to delineate many of the requisite
cellular associations for catfish B cell induction. To date, many
functions of piscine immune systems show similarities to those
found in mammals. For example, it has been reported that catfish B
lymphocytes (sig+) require interaction with both sIg- lymphocytes
(T cells) and macrophages or monocytes in order to generate an
antibody response to T cell dependent (TD) antigens (Miller et al.,
1985). This TD response also initially requires processing and
presentation of the antigen by macrophages (Vallejo et al., 1990). In
contrast to this, B cell responses to T cell independent (TI) antigens
appear to only require the presence of interleukin 1 (IL-1), with no
processing or presentation needed (Miller et al., 1985; Clem et al.,
1985).
Recent advances in piscine lymphocyte culture systems permit
the use of limiting dilution analysis (LDA) as an alternative method
for the assessment of cellular cooperation between lymphocytes in
response to antigen (Tripp, 1988; Arkoosh and Kaattari, 1991). This
method allows for the elucidation of the sequence of B cell
maturation and antigen induced differentiation associated with TI B
cell responses at both early and late phases of this response. The
more conventional methods used to evaluate in vitro piscine B29
lymphocyte responses, such as proliferative responses to mitogens
or anti-hapten plaque forming cell (PFC) responses, typically resolve
only early or late phases of B cell induction by antigen, not both.
Limiting dilution analysis has been used in mammalian systems to
determine the requirements of many immune responses, as well as
to determine the size and frequency of different B cell precursor
populations which are to different antigens (Chen et al., 1992).
However, in lower vertebrates the utilization of LDA techniques in
immunological studies had not been reported until recently. Piscine
LDA studies conducted with coho salmon (Oncorhyncus kisutch)
leukocytes showed that anti-hapten TI PFC responses required a cell
type in addition to the B cell for the generation of an optimal
response. The assumption was made that, as in both catfish and
murine systems, macrophages may be required to assist the B
lymphocyte in response to a TI antigen. Subsequently it was shown
this cell was adherent and displayed macrophage-like
characteristics (Tripp, 1988).
It is reported here that cell free supernatants generated in
vitro from trout leukocyte cultures contain a factor which can
replace adherent cell function in response to the TI antigen TNP-
LPS. To identify the requisite stimulus of this factor non-haptenated
LPS was used as well as TNP-LPS to generate supernatants. This
factor is secreted by the adherent monocyte macrophage cell
fraction from trout peripheral blood leukocytes upon stimulation
with LPS.30
Materials and Methods
Animals. Rainbow trout (Oncorhynchus mykiss, Shasta strain) were
obtained from the Marine/Freshwater Biomedical Sciences Center at
Oregon State University, and maintained at the Salmon Disease
Laboratory in Corvallis, OR. This facility receives fish pathogen-free
water at a constant temperature of 12°C. Fish weight ranged from
300g 500g. Fish were fed Oregon Moist Pellet (OMP) commercial
salmon food daily.
Mitogen and antigen stock preparation. Stock solutions of E. coli
055.B5 lipopolysaccharide (LPS) (Sigma Chemical Company, St. Louis,
MO) were diluted in RPMI 1640 to a concentration of 10 mg/ml and
pasteurized by incubation in a 70°C water bath for 1 hour.
Trinitrophenylated-lipopolysaccharide (TNP-LPS) was
prepared as described previously (Jacobs and Morrison, 1975). TNP-
LPS was pasteurized for 45 minutes in a 70°C water bath and stored
at 4°C.
Cell preparation and tissue culture. Peripheral blood samples were
obtained from fish sacrificed by anesthetic overdose (Kaattari and
Irwin, 1985) in benzocaine (ethyl p-aminobenzoate, Sigma).
Leukocytes were isolated from peripheral blood by using Ficoll-
histopaque (Sigma) separation techniques and cultured in tissue
culture medium (TCM) consisting of RPMI 1640 (Gibco, Grand Island,
NY) with sodium bicarbonate supplemented with 2% autologous
trout plasma and 0.05 mg/ml gentamycin sulfate (Whittaker
Bioproducts Inc., Walkersville, MD) as previously described
(DeKoning and Kaattari, 1991).
Peripheral blood leukocytes (PBL) were fractionated into
lymphocyte and macrophage populations by adherence to plastic as
described previously (Secombes, 1990), with minor modifications.
Briefly, 3x107 to 6x107 blood or kidney leukocytes were added to31
each well of 6 well, flat bottom tissue culture plates (Corning Glass
Works, Corning, NY). All wells were pretreated at 17°C overnight
with 3 ml of a 10 pg/ml solution of bovine fibronectin (Sigma) in
sterile water. Leukocytes were incubated for at least two hours at
17°C in a blood-gas environment. After this incubation the non-
adherent cells were gently removed from the plates by aspiration
with a Pasteur pipette and transferred to new fibronectin-coated
plates and incubated for an additional two hours at 17°C. The
remaining adherent cells were washed three times with
unsupplemented RPMI 1640 to remove any contaminating non-
adherent cells. The adherent macrophage cells were removed from
tissue culture plates by gentle scraping with a rubber scraper
(Becton Dickinson, Lincoln Park, NJ). Lymphocyte (adherent-
depleted) fractions were derived from only the final non-adherent
fraction of leukocytes produced from three sequential adherence
fractionation steps.
Individual leukocyte fractions were tested for both non-
specific leukocyte esterase (Sigma) and slg staining using a
monoclonal anti-trout Ig (DeLuca et al., 1983). Characteristics of PB
leukocyte fractions are listed in Table 2.1. In this report, because of
the reported staining characteristics and for the sake of
convenience, the adherent leukocytes are referred to as
macrophages and non-adherent leukocytes are referred to as
lymphocytes.
Generation of supernatants. Supernatants were generated by
culturing PBL in tissue culture medium (described above) at 2x107
cells/ml. Cells were cultured with 0.4 pg/nil TNP-LPS or LPS for
two days, after which time the cells were washed three times with
unsupplemented RPMI 1640 to remove any residual TNP-LPS or
LPS. The cells were then resuspended in tissue culture medium at a
density of 2x107 cells/m1 and cultured for an additional four to five
days, at which time the culture supernatants were harvested by
removal from tissue culture plates. To ensure the removal of cells
and debris, supernatants were centrifuged at 1000 x g for 1032
minutes and carefully removed from the cell/debris pellet.
Supernatants were aliquoted and stored at -20°C for later use.
Supernatants were generated from cell cultures heterologous
to those cell cultures being tested, except where noted. All
supernatants were used at 50% by volume and added to cells upon
initiation of cultures unless otherwise noted.
Plaque forming cell assay. On the day of harvest,96well culture
plates were centrifuged for 5 minutes at 500 x g. The culture
supernatants were removed and cells were resuspended with 200
p1 unsupplemented RPMI1640per well. Cells secreting anti-TNP
antibody were then enumerated by Cunningham plaque assay as
previously described (Kaattari and Yui,1987).
Limiting dilution analysis. Limiting dilution analysis was performed
as described previously (Tripp,1988;Arkoosh,1990)with little
modification. Briefly, responder cells were diluted to the appropriate
concentrations with the filler cells thus maintaining a constant
concentration of 2x107 cells/ml. In these assays, a standard
requirement for the filler cell population is that they must not be
able to produce antibodies. To ensure this, filler cells were
generated by exposing leukocytes to 6000 rads of 60Co radiation in
the low flux region of a gamma irradiator. Aliquots of 10 p1 were
then distributed to each well of 60 well microculture plates
(Intermountain Scientific Corporation, Bountiful, UT) containing
irradiated adherent leukocytes (3000 rads) as a source of accessory
cells. Tissue culture medium was used in all LDA cultures. For each
frequency determination, at least 3 different responder
concentrations were assayed with a minimum of 60 replicate
cultures per concentration. Negative standards were defined in each
experiment by a set of 60 cultures receiving only filler cells plus
accessory cells and TNP-LPS. Cells from individual wells were
harvested for determination of plaque-forming cells on day 7 of
culture. The LDA data were analyzed according to methods
previously described (Lefkovits and Waldman, 1979).33
Determination of the molecular weight of accessory factor.
Molecular sieve column chromatography was used to isolate the
active fraction(s) of supernatants. The inert carrier, Sephadex G-100
(Pharmacia, Upsula, Sweden) was prepared as described previously
by Tripp (1988). The column (30 ml bed volume) was calibrated
using four distinct molecular weight marker proteins (Sigma): alpha-
lactalbumin (14.2kD), carbonic anhydrase (29kD), ovalbumin (45kD),
and bovine serum albumin (66kD monomer). Upon calibration, 3 ml
of Centriprep 3 (Amicon, Inc., Beverly, MA) concentrated
supernatant was applied and fractions were collected in the elution
buffer pH 7.3 consisting of 100mM sodium chloride and 20mM
sodium phosphate (dibasic, anhydrous) in distilled water. Upon
elution, fractions were concentrated again, then dialyzed overnight
at 4°C against one liter of RPMI 1640 using Spectra/Por 1 cellulose
membranes (Spectrum, Houston, TX). Fractions were then filter
sterilized and tested for activity as measured by the augmentation
of lymphocyte PFC responses.34
Results
Requirement for macrophage (adherent leukocytes) in the
generation of antibody responses. Isolated lymphocyte (non-
adherent) and monocyte/macrophage (adherent) populations
demonstrated greatly impaired ability to generate antibodies in
response to TNP-LPS (Figure 2.1). This impairment was not due to
damage incurred during the fractionation procedure as mixing (1:1)
of the two populations resulted in the complete restoration of the
antibody response. The residual PFC response (approximately 100
PFC/106 cells) in fractionated populations was likely due to
contamination of macrophages by lymphocytes in these cultures
(Table 2.1).
As this response was induced by a T-independent antigen, it
seemed likely that macrophages may be required for accessory
function by the B lymphocyte. One such function would be the
expression of a requisite soluble factor or interleukin. Supernatants
were thus procured by antigenic stimulation of whole leukocytes.
These supernatants were added to fractionated and unfractionated
leukocytes. Addition of supernatant from stimulated leukocytes
completely restored the PFC response to lymphocytes, while
effecting no enhancement of the marginal PFC response from
macrophages (Figure 2.2). These results, representative of 10
separate experiments, indicate that supernatants generated from
leukocyte cell cultures contain a factor(s) which can replace the
accessory role of macrophages required for TI anti-hap ten PFC
responses.
Macrophage-derived cell-free supernatants can restore lymphocyte
antibody responses. In order to determine which leukocyte cell
fraction produces the soluble factor(s) responsible for the restored
response observed in the above experiments, supernatants were
generated from macrophage and lymphocyte fractions cultured35
separately. These supernatants were then assayed for activity in
lymphocyte cultures for their ability to provide the required
accessory function in response to antigen. Results from one
experiment, representative of seven experiments performed, are
shown in figure 2.3. Responses from lymphocytes cultured with
supernatants generated from the lymphocyte cultures were
equivalent to negative control cultures containing no supernatants.
Lymphocyte cultures receiving macrophage-derived supernatants
exhibited significantly higher anti-hapten PFC responses than the
corresponding negative control cultures. Supernatants generated
from macrophage cultures consistently augmented lymphocyte
cultures greater than any other fraction tested. This indicates that
macrophage-derived cell-free supernatants contain a factor(s) which
can provide the accessory function that is required for generating
the antibody response to TNP-LPS.
Limiting dilution analysis (LDA) reveals a mode of action of
supernatant "factor(s)". Determination of the mode of action of the
supernatant "factor" on rainbow trout lymphocytes was achieved by
the use of LDA. This analysis can be used to dissect antibody
responses into early and late phases. Analysis of both unfractioned
leukocyte and lymphocyte cultures revealed that the conditions
used were not limiting for one cell type (Figures 2.4 and 2.5).
However, addition of a small aliquot of macrophages to each well
generated a curve indicative of single hit kinetics (Figure 2.4).
Therefore, it is apparent that trout B lymphocytes require a
macrophage-derived accessory functions in order to generate an
optimal PFC response to TNP-LPS in vitro. To test if supernatants
can provide these required accessory function(s) generated from
macrophages LDA was performed using lymphocyte cultures
supplemented with these supernatants. As shown in figures 2.4 and
2.5, single hit kinetics (linear plot) can be generated in LDA cultures
by the simple addition of macrophage-derived supernatants. This
experiment also indicates that cell to cell contact between B cells
and accessory cells is not an absolutely required accessory function.36
Titration of this macrophage-derived supernatant in limiting
dilution analysis cultures resulted in an increase in the lymphocyte
precursor frequency (Figure 2.5). This suggests that the accessory
factor effects lymphocytes at the early stages of PFCresponses.
Moreover, the mechanism of this effect is to increase the numbers of
pre-B cells available to respond to antigenic stimulus.
Determination of the accessory factor molecular weight.
Determining the molecular weight of the accessory factor was
acheived by the use of molecular sieve column chromatography. The
resulting eluates were tested for accessory activityas measured by
the ability to augment lymphocyte PFC responses. As shown in
figure 2.6, the active fraction in macrophage-derived supernatants
elute at a molecular weight range from 19-24kD. No other fractions
had accessory activity in these supernatants.
LPS induces IL-1-like factor production. In order to ascertain
whether the LPS signal alone is sufficient for the elaboration of IL-
1-like activity, 0.4pg/m1LPS was compared to 0.4pg/m1TNP-LPS.
In the absence of the hapten (TNP) on TNP-LPS, the induction of this
factor can be verified, as shown in figure 2.7. Stimulation by
0.4pg/m1TNP-LPS or 0.4pg/m1LPS results in the generation of
supernatants with similar accessory activities. This verifies LPS as
the inducing stimulus of the IL-1-like factor.37
Discussion
It is shown here that adherent, esterase-positive, sIg-
leukocytes (monocytes/macrophages) are required for accessory
function in the generation of antibody to a T-independent (TI)
antigen, TNP-LPS. Most importantly it was shown that the
mechanism of this macrophage accessory function does not require
direct cell to cell contact. Previous studies in both mammalian and
other piscine systems have shown that cell-free supernatants
generated by LPS-stimulated macrophages supply accessory cell
function for TI PFC responses of cultures depleted of macrophages
(Miller et al., 1985; Clem et al., 1985). Establishment of monokine
secretion as the mode of accessory cell function in trout was
achieved by employment of cell fractionation techniques.
Macrophages were separated from rainbow trout peripheral blood
leukocyte suspensions using adherence and multiple passages onto
fibronectin-coated surfaces before cultured in the presence of TNP-
LPS. These macrophage-derived cell-free supernatants were then
assayed for the ability to replace macrophages in the induction of in
vitro antibody responses. In addition, non-haptenated LPS was used
to stimulate cells in order to verify the requisite stimulus for
producing this factor. The lymphocyte antibody response was
restored upon the addition of TNP-LPS- or LPS-derived
supernatants. Therefore, at least one factor of accessory cell function
in rainbow trout is the production of a biologically active
monokine(s). Molecular weight fractionation studies indicate that
this monokine has an approximate molecular weight of 19-24kD
(Figure 2.6). Because of the accessory activity, macrophage source,
and molecular weight data we suggest that the predominantly active
monokine in these supernatants is an IL-1-like factor.
The LDA confirms and further elucidates the mode of action of
the monokine particularly when coupled with cell fractionation
techniques. The in vitro form of LDA utilizes microculture38
techniques to permit isolated development of functional clones of B
lymphocytes from a single precursor (Lefkovits and Waldman,
1979). Thus LDA results in the quantitative analysis of B cell
precursor frequency and clone size, as well as the determination of
cellular cooperativity. In this study the requisite for more thanone
cell type was indicated by the non-linear kinetics exhibited by
lymphocyte cultures in response to TNP-LPS (Figures 2.4 and 2.5).
Linear kinetics occurred when the lymphocyte fraction was
coincubated in a saturating concentration of either macrophagesor
macrophage-derived supernatant (Figure 2.4). Thus,as supernatant
is sufficient for the generation of linear kinetics, actual physical
contact between the macrophage and B lymphocyte is not required.
These findings are comparable to the accessory role of macrophages
observed in the murine system, wherein MHC-II- (negative) IL-1
producing adherent cells are fully capable of supplyingaccessory
function, whereas MHC-II+ (positive) non-IL-1 producing cells
cannot do so (Sinha et al., 1987). In mammalian systems it has also
been reported that IL-1 has a direct role in B cell activation and IL-
1 secretion is the only accessory cell function required for TI B cell
activation (Yamaga et al., 1978).
The utilization of limiting dilution analysis for the study of
lower vertebrate immune responses has not been reported until
recently (Tripp, 1988; Arkoosh and Kaattari, 1991). These initial
limiting dilution studies revealed that upon dilution of unfractioned
leukocyte populations multi-hit kinetics were observed indicating
that minimally two cell types were required for generating a
positive response. When saturating concentrations of macrophages
were added to LDA cultures the comparable dilution of whole
leukocytes yielded single-hit kinetics. In the study reported here it
is shown that restoration of at least one macrophage accessory cell
function can be acheived by the addition of supernatants generated
by LPS stimulation of leukocyte as well as macrophage cell cultures.
Column chromatography fractionation of these supernatants using a
molecular sieve column revealed a biologically active peak eluting at
19-24kD (Figure 2.6). Based on these findings and those previously39
reported in both mammalian and piscine systems it is proposed that
IL-1 or an IL-1-like factor is the monokine required for trout
accessory function to TI antigens.
The fact that cytokines play an important immunoregulatory
role in piscine systems has been demonstrated by several
investigators. The action of cytokines on both specific and non-
specific immune cells in fish has been the focus of several reports.
Rainbow trout lymphocytes have been shown to secrete a factor
which directly affects macrophages (Secombes, 1987; Graham and
Secombes, 1990a; Graham and Secombes, 1990b). Catfish
macrophages have been shown to secrete a cytokine that serves an
accessory function in TD anti-hapten antibody responses (Clem et al.,
1985). It has also been reported that stimulation of catfish long
term monocyte cultures with LPS induces secretion of high and low
molecular weight species of IL-1 that are biologically active for
catfish as well as mouse T cells (Vallejo et al., 1991). A biologically
active invertebrate cytokine which can be blocked with antibodies
to mammalian IL-1 alpha has been extracted from starfish
coelomocytes (Burke and Watkins, 1991), and invertebrate
hemocytes have been shown to react to human TNF and IL-1
(Hughes et al., 1991). Given this information it is likely that the LPS
stimulated rainbow trout macrophages in our study are secreting at
least one IL-1-like monokine which can restore the TI PFC
responses of lymphocyte cultures. Although very likely, it has yet to
be determined if more than one monokine is being produced and
secreted by these macrophages.
It is interesting to note the increase in B cell precursor
frequency in lymphocyte cultures supplemented with increasing
concentrations of leukocyte derived supernatants (Figure 2.5). One
explanation for this is that there are subpopulations of B
lymphocytes with differing sensitivities to IL-1. Therefore there is a
lower frequency observed when the concentration of supernatant is
only 50%, but much greater when 90%. A sensitive population is
triggered by the relatively low dose of supernatant while the
sensitive and relatively insensitive population are triggered by the40
high dose of supernatant. Another possible explanation is that when
the concentration of IL-1 in the culture medium is very low the B
lymphocyte can only be activated when in close proximity to an
activated, IL-1 secreting macrophage. Only the antigen-activated B
precursors that are proximal to IL-1 secreting macrophages will be
able to accrue enough IL-1 to differentiate into antibody producing
cells. However, if an IL-1 containing supernatant is supplied, then
the concentration of IL-1 may be sufficiently high so as to permit a
greater percentage of B lymphocyte precursors to differentiate. In
this scheme, no presentation or processing of the TI antigen is
required, since no cell-cell contact is required. Another implication
of this data is that the antigen itself must activate the B lymphocyte
to a stage of IL-1 receptive differentiation. At this stage provision of
IL-1 completes the differentiative sequence leading to the
production of antibody. Whether antigen can provide an initial first
activation step for TD antigens has yet to be addressed. A model
based upon the above studies which describes piscine B cell
responses to TI antigens has been reported recently (Kaattari,
1992).
These studies indicate that rigorous macrophage cell depletion
methods must be used to demonstrate this fact. Sizemore et al.
(1984) have shown that nonadherent leukocyte cultures containing
as little as 1% macrophages permit mitogenic responses to both Con
A and LPS that were nearly indistinguishable from those of
unfractionated cells. In our studies, depletion of adherent
macrophages by multiple passages onto fibronectin-coated surfaces
was found to be an efficient and simple method. Although the
adherence method used in this study is quick and convenient for the
removal of most macrophages, ostensibly some B cells appear to be
present in the adherent cell or macrophage fraction thus a limited
PFC response was elicited. It is also likely that some macrophages
were not removed from the macrophage depleted or non-adherent
population using the adherence technique and provided limited
accessory cell function for a minimal PFC response (Figures 2.1 and
2.2).41
In conclusion, based on previous studies and the findings
reported here it is becoming increasinglyapparent that the
induction of humoral immune reactionsare mediated through
macrophage functions similar to those observed in higher
vertebrates. Further investigation and elucidation of the functionof
macrophages and macrophage-derived soluble mediators invarious
piscine and invertebrate systemsmay reveal this similarity to
higher vertebrates as well as further support theuse of piscine
immune systems as simple and useful immunological models for
higher vertebrates.42
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Leukocyte cell
fraction
% surface Ig+ % non-specific
esterase+
Unfractionated 51 18
Adherent 2 96
Non-adherent 62 3
Table 2.1: Characteristics of adherence fractionated
leukocyte populations. The percentage of cells expressing
surface immunoglobulin (slg +) was evaluated by immunofluorescent
staining methods described previously (DeLuca et al., 1983). Non-
specific esterase tests were performed as indicated by the
manufacturers instructions (Sigma, alpha-Napthyl Acetate Esterase
kit).44
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Figure 2.1: In vitro antibody responses of adherence
fractionated trout PBL. Unfractionated (Unfr.), adherent (Mo+),
non-adherent or lymphocytic (Mei), and re-mixed (Mo+ + Mei-)
leukocytes were cultured at a concentration of 107 cells/ml in 100p1
tissue culture medium containing 0.4pg/m1TNP-LPS. All cultures
were assayed for anti-TNP antibodies on day 9. The number of PFCs
per 106 cells were plotted for each corresponding fraction of
leukocytes cultured. Each bar represents the mean of 3 cultures
containing 106 leukocytes each and the error bar represents 1
standard deviation from the mean.600
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Figure 2.2: In vitro antibody responses of adherence
fractionated PBL supplemented with supernatants. Cells
were cultured at 107 cells/ml in 100p1 tissue culture medium
containing 0.4pg /ml TNP -LPS supplemented with 50% tissue
culture medium (U) or 50% leukocyte derived supernatants (U) by
volume. Supplements were added to culturesupon initiation and all
cultures were harvested on day 9. The number of PFCsper 106 cells
were plotted for each corresponding fraction of leukocytes cultured.
Each bar represents the mean of 3 cultures containing 106
lymphocytes each and the error bar represents 1 standard deviation
from the mean...z,
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Figure 2.3: The effect of supernatants generated from
individually fractionated and cultured leukocytes on
antibody production. Supernatants were generated from LPS
stimulated unfractioned (Unfr.), macrophage (Mo+), macrophage
depleted (Mo-), and macrophage depleted leukocytes supplemented
with macrophages (Mo- + Mo+) cultures. Lymphocytes were cultured
at 107cells/m1 in 100p1 tissue culture medium containing 0.4pg /ml
TNP-LPS plus 50% of each supernatant (by volume). Control cultures
containing unfractionated leukocytes were assayed for comparison.
The number of PFCs generated were plotted for each corresponding
culture. Each bar represents the mean of 3 cultures and the error
bar represents 1 standard deviation from the mean.1W
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Figure 2.4: Limiting dilution analysis of lymphocytes
cultured with macrophages or macrophage-derived
supernatants. Lymphocytes were cultured alone (-0,-) or in the
presence of either macrophages (---) or 50% macrophage-derived
supernatant (-.--). All lymphocytes were cultured in tissue culture
medium containing O.4pg /ml TNP-LPS. The supernatant was added
upon culture initiation. All cells were harvested on day 7 of culture
and the fraction of non-responding wells were plotted for each
corresponding number of responding lymphocytes per well. Sixty
replicate cultures were analyzed for each responder cell
concentration.100
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Figure 2.5: Limiting dilution analysis of lymphocyte cultures
supplemented with supernatants. Lymphocytes were cultured
at 107 cells/ml in tissue culture medium containing 0.4pg /ml TNP-
LPS supplemented with either 0% (), 50% (), or 90% ()
supernatants by volume. Supernatants were added to cultures upon
initiation. Cells were harvested on day 7 of culture and the fraction
of non-responding wells were plotted for each corresponding
number of responding lymphocytes per well. A minimum of 60
replicate cultures were analyzed for each responder cell
concentration.30
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Figure 2.6: The elution profile for accessory activity in
chromatographed macrophage-derived supernatants. Solid
circles represent the elution profiles of protein molecular weight
markers: alpha-lactalbumin (14.2kD), carbonic anhydrase (29kD),
chicken egg albumin (45kD), and bovine serum albumin (66kD). The
open circle represents the molecular weight at which accessory
activity was displayed.300
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Figure 2.7: Comparison of TNP-LPS- and LPS-derived
supernatant IL-1-like activity. All supernatants were
generated by culturing leukocytes in TCM supplemented with
0.4pg /ml TNP -LPS or 0.4pg/m1LPS for four days. Lymphocytes
were cultured at 107 cells/nal in TCM supplemented with 50%
supernatants by volume in the presence (11 ) or absence () of
antigen. The number of PFCs generated was plotted for each
supernatant tested. Each bar represents the mean of three replicate
cultures and the error bar represents one standard deviation from
the mean.51
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Abstract
It has been previously shown that rainbow trout macrophages
produce and secrete an IL-1-like monokine which can provide an
accessory function required for the generation of an in vitro T-
independent antibody response. It is shown here that this IL-1-like
factor, as measured by the provision of accessory function for
antibody responses, is produced as early as 24 hours and attains its
highest concentration by day 4 post LPS stimulation. Stimulation
with high (200pg/m1) and low (0.2pg/m1) doses of LPS generates
supernatants with different activities. These activities include
polyclonal activation of lymphocytes in the absence of antigen, as
well as an accessory role in antigen specific responses. Stimulation
of leukocytes with a low dose of LPS appears to only induce the IL-
1-like accessory factor, whereas high doses of LPS induce a factor
which polyclonally activates lymphocytes. This difference in activity
is also demonstrated by the adsorption of supernatants onto
paraformaldehyde-fixed lymphocytes. High dose LPS supernatant
activity is reduced following adsorption with either non-activated or
antigen-activated lymphocytes, whereas low dose LPS supernatant
activity is reduced only when adsorbed with antigen-activated
lymphocytes. This demonstrates the presence of at least two
separate cytokine factors with distinct biological activities. This also
suggests that lymphocyte surface receptors for polyclonal activating
factor are present on both antigen- and non-activated lymphocytes,
while only activated lymphocytes express a surface receptor for the
IL-1-like factor. Finally, the addition of factor to cultures at later
stages of the PFC response decreases its efficiency in providing the
accessory activity required for anti-hapten PFC responses of
lymphocytes.53
Introduction
A wide variety of known nonspecific, soluble mediators exist
that regulate both the afferent and efferent limbs of the immune
response. These include interleukins 1 (IL-1) through 13 (IL-13),
each having somewhat distinct but pleiotropic regulatory functions.
Interleukin one (IL-1) was first detected in cultures of human
peripheral blood adherent cells, and the biological properties
originally ascribed to this molecule included the synergistic
enhancement of the proliferative responses of murine splenocytes
and thymocytes to lectins such as Con A and PHA, as wellas the
enhancement of antibody production by T cell depleted splenocytes
(reviewed by Dinarello, 1990). Presently, IL-1 is known to affect B
and T cell proliferation and function (Corbel and Melchers, 1984;
Pike and Nossal, 1985; Sinha et at, 1987; Inaba and Steinman,
1986). IL-1 also has been demonstrated to increase the expression
of immunolglobulin (Ig) receptors, as well as to promote the
expression of differentiation antigens on T cell membranes
(Hagicuara et at, 1987; Bonnefoy et al., 1989). It has been
demonstrated that IL-1 has a direct role in B cell activation and IL-
1 secretion is the only accessory cell function required in T
independent (TI) B cell activation (Sinha et al., 1987). Induction of T
dependent (TD) B cell responses are also dependent on the
elaboration of IL-1 by accessory cells (reviewed by Unanue, 1984).
Thus it is clear that IL-1 is an important accessory factor in both TI
and TD B cell responses.
Stimulation of catfish monocyte cell lines with LPS induces
secretion of relatively high levels of high and low molecular weight
species of IL-1 that are active on both catfish and mouse T cell lines
(Vallejo et al., 1991). It has also been shown that in vitro activation
of fish primary macrophage cultures induces the elaboration of IL-1,
which appears to be required for both TI and TD B cell responses
(Clem et al., 1985). In addition, interferon and macrophage-54
activating factor have been elicited from salmonid leukocytes. These
two distinct cytokines appear to possess comparable macrophage-
activating functions as observed in mammals (Graham and
Secombes, 1990; Smith and Braun-Nesje, 1982). In the catfish
system it has been reported that B cell responses to TI antigens
appear only to require the presence of macrophage-derived IL-1
(Clem et al., 1985), with no processing or presentation needed.
To define interleukins which have the capacity to activate B
cells and mediate their growth and maturation to antibody-secreting
cells, the induction of Ig secretion by B cells or B cell lines is often
used (Isakson et al., 1982; Pure et al., 1983). In piscine studies,
however, the current lack of B cell lines available hinders the study
of interleukins. Subsequently, piscine interleukins have been
characterized by measuring the indirect effects of culture
supernatants on target primary leukocyte populations in vitro.
The goal of this study was to characterize the production and
effects of an IL-1-like factor which is secreted by LPS-stimulated
trout macrophages. Because of the relatively low yield of purified
macrophages in our system, unfractionated leukocytes were used to
generate supernatants. Interestingly, stimulation of leukocytes with
high (200pg /ml) and low (0.2pg /ml) doses of LPS generated
supernatants with different activities. The induction of these factors
and their receptors are characterized and discussed in this study.55
Materials and Methods
Animals. Rainbow trout (Oncorhynchus mykiss, Shasta strain)were
obtained from the Marine/Freshwater Biomedical Sciences Center at
Oregon State University, and maintained at the Salmon Disease
Laboratory in Corvallis, OR. This facility receives fish pathogen-free
water at a constant temperature of 12°C. Fish weight ranged from
300g 800g. Fish were fed Oregon Moist Pellet (OMP) commercial
salmon food daily.
Mitogen and antigen stock preparation. Stock solutions of E. coli
055.B5 lipopolysaccharide (LPS) (Sigma) were diluted in RPMI 1640
to a concentration of 10 mg/ml and pasteurized by incubation in a
70°C water bath for 1 hour.
Trinitrophenylated-lipopolysaccharide (TNP-LPS) was
prepared as described previously (Jacobs and Morrison, 1975). TNP-
LPS was pasteurized for 45 minutes in a 70°C water bath and stored
at 4°C.
Cell preparation and tissue culture. Peripheral blood sampleswere
obtained from fish sacrificed by anesthetic overdose in benzocaine
(ethyl p-aminobenzoate, Sigma Chemical Company, St. Louis, MO).
Leukocytes were isolated and cultured in tissue culture medium
consisting of RPMI 1640 (Gibco, Grand Island, NY) with sodium
bicarbonate supplemented with 2% autologous trout plasma and
0.05mg/m1 gentamycin sulfate (Whittaker Bioproducts Inc.,
Walkersville, MD) as previously described (DeKoning and Kaattari,
1991).
Peripheral blood leukocytes (PBL) were fractionated into
lymphocyte and macrophage populations by adherence to plasticas
described previously (Secombes, 1990), but with minor
modifications. Briefly, 3 to 6x107 blood leukocytes were added to
each well of 6 well flat bottom tissue culture plates (Corning Glass56
Works, Corning, NY). All wells were pretreated at 17°C overnight
with 3 ml of a 10pg/m1 solution of bovine fibronectin (Sigma) in
sterile water. Leukocytes were incubated for at least two hoursat
17°C in a blood-gas environment. After this incubation, thenon-
adherent cells (lymphocytes) were removed from the plates by
aspiration with a Pasteur pipette and transferred to new
fibronectin-coated plates, while the remaining adherent cellswere
washed three times with unsupplemented RPMI 1640 toremove
any contaminating lymphocytes. For macrophage/monocyte
depleted fractions, only the final non-adherent fraction of
lymphocytes produced from 3 sequential fractionation stepswas
used in experiments to avoid contamination of macrophages.
Adherent cells were removed from tissue culture plates by gentle
scraping with a rubber scraper (Becton Dickinson, Lincoln Park, NJ).
This procedure results in 96% esterase-positive cells in the adherent
fractions and 97% lymphocytes in the non-adherent fractions
(Ortega and Kaattari, 1993a).
Generation of supernatants. Supernatants were generated by
culturing PBL in tissue culture medium containingan appropriate
dose of LPS at 2x107 cells/ml. On the appropriate day of harvest,
supernatants were removed from cultures and centrifuged at 1000
x g for 10 minutes, then passed through 0.2pm filters (Schleicher
and Schuell, Inc., Keene, NH) to remove the remaining LPS in
supernatants. Filtered supernatants were stored at -20C° for later
use.
Supernatants were generated from cell cultures heterologous
to those tested, except where noted. All supernatants were used at
50% by volume and added to cells upon initiation of cultures unless
otherwise noted.
Adsorption of supernatant accessory activity by incubation with
lymphocytes. Peripheral blood leukocytes and red blood cells (RBC)
were cultured at 107 cells/ml for 3 days in either tissue culture
medium (TCM) supplemented with 0.4pg/m1TNP-LPS (antigen-57
activated) or unsupplemented TCM (non-activated). On the third day
all cells were washed 3 times with unsupplemented RPMI, and fixed
with 4% paraformaldehyde dissolved in phosphate-buffered saline
(PBS; pH 7.4) for 2 hours at 4°C. After fixation, the cellswere
washed once with PBS, then three times with unsupplemented
RPMI. Following the final wash 108 paraformaldehyde-fixed,
antigen- or non-activated cells were resuspended in 0.5 ml of either
high (200pg /ml) or low (0.2pg /ml) dose LPS-derived bulk stock
supernatants and adsorbed 18 hours at 17°C, after which the
adsorbed supernatants were harvested as described above. The
accessory activity of adsorbed supernatants was compared to their
corresponding unadsorbed supernatant activity by evaluating their
ability to augment TNP-LPS induced plaque forming cell (PFC)
responses.
Mitogen Assay. Twenty hours prior to harvest, 10p1 (1pCi) of 3H-
thymidine, specific activity of 6.7 Ci/mmol, (ICN Biomedicals, Inc.,
Irvine, CA) diluted in RPMI was added to each well. Cellswere
harvested as previously described by (Kaattari and Yui, 1987).
Results are expressed as either counts per minute (cpm)or
stimulation indices (cpm of cultures with mitogen/cpm of cultures
without mitogen).
Plaque forming cell assay. On the day of harvest, 96 well culture
plates were centrifuged for 5 minutes at 500 x g. The culture
supernatants were removed and cells were resuspended in 200 pl
unsupplemented RPMI per well. Cells secreting anti-TNP antibody
were then enumerated by Cunningham plaque assay as previously
described (Arkoosh and Kaattari, 1991).
Determinadon of the molecular weight of cytokine factors.
Molecular sieve column chromatography using Sephadex G-100
(Pharmacia, Upsula, Sweden) was prepared as described previously
by Tripp (1988). The column (30 ml bed volume) was calibrated
using five distinct molecular weight marker proteins (Sigma): alpha-
lactalbumin (14.2kD), carbonic anhydrase (29kD), ovalbumin (45kD),58
and bovine serum albumin (66kD monomer). Upon calibration, 3 ml
of Centriprep 3 (Amicon, Inc., Beverly, MA) LPS-derived
supernatant was applied to the column. Fractions were then
collected in the elution buffer pH 7.3 consisting of 100mM sodium
chloride and 20mM sodium phosphate (dibasic, anhydrous) in
distilled water. Upon elution, fractions were reconcentrated then
dialyzed overnight at 4°C against one liter of RPM' 1640 using
Spectra/Por 1 cellulose membranes (Spectrum, Houston, TX).
Fractions were then filter sterilized and the activity of each fraction
compared as measured by the augmentation of lymphocyte PFC
responses.59
Results
Removal of LPS from culture supernatants. In this study LPSwas
removed from culture supernatants by filtration (0.2pm). This
procedure was deemed essential so that the direct effect of LPS
would not confound analysis. Verification of filtering efficiencywas
accomplished by prefiltering TCM containing LPS prior to
stimulation of cultures. As shown in figure 3.1, PBL cultures neither
proliferate nor produce PFCs when incubated with prefiltered LPS-
supplemented TCM, whereas there is a dose-dependent leukocyte
response to unfiltered LPS-supplemented TCM. This suggests that
LPS can be removed from or reduced to submitogenic levels in TCM
by filtering with 0.2pm membranes. Interestingly,upon incubation
with supernatants filtered after five day LPS stimulation (post-
filtered) PBL both proliferate (Figure 3.1A) and produce PFCs
(Figure 3.1B). This indicates that a non-LPS factorcan induce both
leukocyte proliferation and PFC production in these cultures.
LPS dose response for generation of factor. To determine if the IL-
1-like factor can be induced by using high doses of LPS,
supernatants were generated using increasing doses of LPS and
assayed for accessory activity. Cultures were stimulated with LPS
upon initiation and all supernatants were harvested on day 4. Factor
activity was measured by the augmentation of antigen specific
responses. As shown in figure 3.2, supernatants generated from low
doses of LPS stimulation equally restored lymphocyte PFCresponses
as did 0.4pg/m1 TNP-LPS-derived supernatants. In contrast, high
dose (200pg /ml) LPS supernatants appear to polyclonally activate
lymphocytes. This finding suggests that high and low dose LPS-
derived supernatants may have distinct biological activitiesas
measured by their ability to induce polyclonal activation in
lymphocyte cultures. Alternatively, high dose LPS stimulationmay60
generate supernatants with higher levels of the IL-1-like factor
which may induce antigen non-specific activation.
Determining the molecular weight of cytokine factors. To verify the
presence of a second soluble factor distinct from the IL-1-like
factor, high and low dose LPS-derived supernatantswere
fractionated by molecular weight. Fractionation using molecular
sieve column chromatography revealed that all active fractions
eluted at a range of 19-241(D (Figure 3.3). This suggests that these
supernatants contain either different factors with similar molecular
weights, or simply different concentrations of thesame IL-1-like
factor.
Adsorption of factor activity by lymphocytes. As cytokine actions
are largely mediated by receptors, it was hypothesized that trout
lymphocytes may express distinct surface receptors for the
seemingly distinct active factors in high and low dose LPS-derived
supernatants. To test this, replicate lymphocyte cultures were
established in which one culture was activated with antigen andone
culture was non-activated. After two days, all lymphocyteswere
paraformaldehyde-fixed, and either high or low dose LPS
supernatants were adsorbed with the fixed lymphocytes. Following
adsorption, supernatant activity was measured by both the
provision of accessory activity in PFC responses and mitogenic
stimulation of lymphocytes. As shown in figure 3.4A, high dose LPS-
derived supernatants display both reduced accessory activity in
lymphocyte PFC responses as well as a reduced ability to polyclonal
activate lymphocytes in the absence of antigen following adsorption
with antigen-activated or non-activated lymphocytes. In contrast,
low dose LPS-derived supernatants (Figure 3.4B) do not polyclonally
activate lymphocytes in the absence of antigen, and have reduced
accessory activity only when adsorbed with antigen-activated
lymphocytes. This suggests that at least two separate factors exist
which are induced by stimulating leukocytes with different doses of
LPS. Moreover, this suggests that both antigen-activated and non-61
activated lymphocytes express surface receptors for a high dose
LPS-derived factor, whereas only antigen-activated lymphocytes
express receptors for the low dose LPS-derived factor.
Kinetics of generation of factor. To further characterize these high
and low dose LPS-induced factors, the kinetics of factor generation
was evaluated for each supernatant. The kinetics of generation of
these factors from PBL cultures stimulated with LPSwas ascertained
by stimulating seven replicate cultures with 0.2pg/m1or 200pg /ml
LPS. On the appropriate days, supernatants were harvested and
filtered in order to remove any residual LPS within supernatants.
Supernatant activity was measured by the augmentation of PFC
responses of lymphocyte cultures with or without antigen.
As shown in figure 3.5, high and low dose LPS-derived
supernatants augment PFC responses when harvested as early as 1
day post LPS stimulation. Optimal activity is observed in
supernatants harvested on day 4 or 5 post LPS stimulation and
remains at this level through day 7. This indicates that factorsare
produced and secreted as early as 24 hours post LPS stimulation,
and the generation of factors peak by day 4 post stimulation.
Addition of polyclonal activating factor (high dose LPS supernatant)
to non-antigen activated cultures generates a kinetic response
similar to appear to that response observed in lymphocyte cultures
stimulated with antigen. In contrast, low dose LPS supernatant IL-
1-like factor is produced with slower kinetics, and does not
polyclonaly activate lymphocytes (Figure 3.5).
Determining the relative activity of factor present in supernatants.
In order to establish when these factors are being produced at
optimal levels, the relative activity of supernatants harvestedon
days 0-7 was evaluated. Upon observation of the kinetics data
(Figure 3.5) factor levels in supernatants harvested on days 4-7
appear to be equivalent. But because all supernatants in the kinetics
studies were used at 50% (by volume) it was possible that
saturating levels of these factors were present in those cultures62
supplemented with supernatants harvested after day 4. By titrating
these supernatants the relative levels of factor in each supernatant
can be more accurately evaluated. High and low dose LPS-derived
supernatants were added to lymphocytes cultured in the presence
of antigen and assayed for PFC responses on day 9 of culture.
Titration of high dose LPS supernatants revealed that the relative
units of activity of factor in supernatants markedly increasedon
days 3-7 (Table 3.1; Figure 3.6A), with maximum concentrations of
factor present by days 5 and 6. In contrast, the low dose LPS
supernatants showed a marked increase in factor on days 5-7 (Table
3.1; Figure 3.6B). These data confirm that the kinetics of these two
factors have distinct patterns, which again indicates that thereare
at least two separate factors present in these supernatants.
Kinetics of addition of factor to Me- cultures. In order to determine
when factor is required during the TI PFC response to TNP-LPS,
supernatants were added to PB lymphocyte cultures on days 0-8.
Activity was measured by the restoration of antibody responseas
measured on day 9. Figures 3.7A and 3.7B show that the addition of
factor on days 5-8 shows a reduced restoration of the antibody
responses of both activated and nonactivated lymphocyte cultures.
This indicates that factor is required at a relatively early stage in
the development of an antibody response to TNP-LPS.63
Discussion
The results of this study further characterize the precise
cellular requirements of rainbow trout antibodyresponses by
characterizing factors generated upon LPS stimulation of
macrophage cell cultures. The accessory activity of an IL-1-like
monokine can be measured by the ability of cell-free supernatants
to augment the antibody responses in vitro. Stimulation with high
(200pg /ml) and low (0.2pg/m1) doses of LPS generates
supernatants with distinct activities, namely polyclonal activation
versus accessory cell function. Stimulation with a low dose of LPS
induces the production of an IL-1-like factor whichcan not
polyclonally activate lymphocytes in the absence of antigen,
whereas high dose LPS-derived supernatants containa factor which
can polyclonally activate lymphocytes in the presence or absence of
antigen. This polyclonal activation is measured by the induction of
lymphocyte mitogenesis and antibody production in the absence of
antigen. These separate factors can be detected in supernatantsas
early as 24 hours and are present in optimal levels by day 5 post
LPS stimulation of leukocyte cultures. Furthermore, the adsorption
of these factors with paraformaldehyde-fixed lymphocytes suggests
that both antigen- and non-activated lymphocytesexpress surface
receptors for the polyclonal activating factor(s), whereas only
antigen-activated lymphocytes express surface receptors for the low
dose LPS-derived IL-1-like factor. Finally, the addition of
supernatants to lymphocyte cultures five or more days post
stimulation with antigen results in a reduced capacity to stimulate
lymphocyte PFC response. These data suggest that there are at least
two separate trout cytokines with distinctive activites which can be
induced by different doses of LPS.
The initial approach in establishing whether or not rainbow
trout macrophages function as accessory cells solely by virtue of
secreting a soluble factor (cytokine) was achieved by the use of cell64
separation techniques. The ability of the macrophage population of
rainbow trout peripheral blood leukocytes to producean IL-1-like
accessory factor was assessed by the ability of cell free supernatants
to provide the requisite accessory function for antigen-dependent
antibody responses in vitro. It was previously reported that TNP-
LPS induced PFC responses can be restored by the addition of
macrophage-derived cell free supernatants (Ortega and Kaattari,
1993a). These results indicated that at least one requirement of
accessory cell function in rainbow trout is the production of a
monokine(s), and it was suggested that this monokine isan IL-1 like
factor (Ortega and Kaattari, 1993a).
The studies reported here clearly demonstrate the IL-1-like
factor dependence of TI B cell responses. In agreement with others,
we have found that rigorous macrophage cell depletion methods
must be used to demonstrate this fact. In our studies, depletion of
adherent macrophages by multiple passages over fibronectin-coated
surfaces was found to be an efficient and simple method. In
mammalian systems LPS stimulation of macrophages is used for the
preparation of IL-1-rich macrophage supernatants (Oppenheim et
al., 1986), thus it was logical that LPS may induce IL-1 production in
piscine systems as well. However, it has been reported that B cells
secrete IL-1 (Scala et al., 1984; Gerrard and Volkman, 1985) or
express it in membrane-bound form (Kurt-Jones et al., 1985) under
certain conditions, including LPS stimulation. In addition, since it has
been shown that fetal calf serum may obscure IL-1 dependence of B
cell activation (Hoffman et al., 1984), it is possible that using 2%
autologous plasma may have the same effect in our system. Clearly,
however, in our experiments any putative activity of lymphocyte-
derived IL-1 was not sufficient for inducing or augmenting TI
responses, and the use of autologous plasma does not obscure the
IL-1-like factor dependence of these PFC responses (Ortega and
Kaattari, 1993a).
In this study culture supernatants were generated from
rainbow trout PBL stimulated with LPS. One common problem in
generating biologically active supernatants is the removal of65
mitogen or stimulus source. A technique commonly used to generate
mitogen-free supernatants is to briefly pulse cultures with
mitogens, but in this technique active factors in supernatants may
be removed along with mitogen during the subsequent washing
steps. Thus it is necessary to find a window in which the mitogens
used can activate cells, but factor production is still at a minimum.
Ideally, this will keep factor loss at a minimum while ensuring the
removal of mitogen from cultures. In order to remove LPS from
culture supernatants while still retaining the IL-1-like factor, the
supernatants in this study were filtered using 0.2pm membranes. If
a residual amount of LPS was present after filtering, it could not be
detected by 3H thymidine incorporation assays (Figure 3.1).
Submitogenic or residual doses of LPS have no effect on the TI anti-
hapten lymphocyte PFC responses in our assays (Figure 3.1). Thus
the active factor(s) in our supernatants are derived from leukocytes
and were not introduced exogenously.
In this study low doses of LPS (0.2pg /ml) were used to
generate an IL-1-like accessory factor. In contrast, a high dose LPS
was capable of generating a polyclonal activating factor. Although
supernatants generated from both doses of LPS could restore the
PFC responses of lymphocytes cultured in the presence of antigen
(TNP-LPS), only high dose LPS-derived supernatants induced the
polyclonal activation of lymphocytes in the absence of antigen
(Figures 3.2, 3.4). This observed difference may be a result of one or
several events. A simple explanation for this is that there is a single
or homogenous population of macrophages which are sensitive to
different doses of LPS. Upon stimulation with a low dose of LPS,
these macrophages produce IL-1, whereas after high dose LPS
stimulation or either both IL-1 and polyclonal activating factor or
just polyclonal activating factor is produced. Another possibility is
based on the assumption that there is a population of low dose LPS-
responsive macrophages present in the leukocyte cultures which
produce the monokine(s) responsible for inducing the polyclonal
activation observed in lymphocyte cultures. Such LPS tolerant
macrophages may be unable to respond to low doses of LPS.66
Therefore, upon stimulation with low doses of LPS these tolerant
macrophages failed to produce the polyclonal activating factor but
can produce the IL-1-like factor required for lymphocyte antigen-
dependent PFC responses. When stimulated with a highly mitogenic
dose of LPS these tolerant macrophages generate the polyclonal
activating factor as well as the non-tolerant cells. LPS-specific
tolerance has been previously shown to be broken by high doses of
LPS (Venkataraman and Scott, 1977) in mammalian studies. This
possibility suggests that although the tolerant cellsare anergic to
stimulus by submitogenic doses of LPS, they are not clonally deleted
and can receive stimulatory signals from mitogenic doses of LPS.
Yet another possibilty, although unlikely, is that cellular
proliferation is required for the production of the factor(s) which
induces polyclonal activation in lymphocyte cultures. Inagreement
with previously published observations (Kaattari and Yui, 1987),
0.2pg/m1 LPS is submitogenic, whereas 200pg /ml LPS is highly
mitogenic for trout leukocytes. Although still controversial, it has
been reported that B cell proliferation appears to benecessary for
the generation of antibody-forming cells in many mammalian in
vitro model systems (Chace and Scott, 1988; Jelinek and Lipsky,
1983), but this has yet to be reported in piscine systems. However,
others have reported that some human polyclonal activators
(including LPS) are capable of inducing B cell differentiation into
PFCs in the absence of cell division (Grayson et al., 1981).
A more likely explanation of this difference in supernatant
activity is that there are at least two populations of responding
macrophage subpopulations, one sensitive to low doses LPS and the
other requiring high doses of LPS to stimulate factor production. In
this study, these distinct subpopulations are producing factors with
similar molecular weights but vary in their ability to induce
lymphocyte polyclonal activation when cultured without antigen.
Moreover, because the of the low yield of macrophages in our
culture system, supernatants were generated from unfractionated
leukocytes. Thus it is possible that these factors are produced by
different cell types. The IL-1-like factor has been previously67
identified and shown to be produced by macrophages (Ortega and
Kaattari, 1993a). However, it is possible that the polyclonal
activating factor present in high dose LPS supernatants is produced
by the lymphocyte population in stimulated leukocyte cultures.
Rainbow trout lymphocytes have been shown by Graham and
Secombes (1990) to secrete a factor which directly effects
macrophage function.
The relative activity levels of both the IL-1-like and
polyclonal activating factors (Table 3.1) indicate that both
supernatants contain similar levels of their respective factors by
day 5. The observation that it takes longer for the IL-1-like factor to
achieve its optimal level, coupled with the adsorption data in figure
3.4 suggests that there are at least two separate factors produced in
these studies. This would indicate that the differences observed
between high and low dose supernatants in the receptor adsorption
studies (Figure 3.4) are likely due to the presence of separate
receptors on non-activated and antigen-activated lymphocytes. This
suggests that there is a unique receptor on activated lymphocytes
that recognizes the IL-1-like factor, whereas the polyclonal
activating factor receptor appears to reside on both activated and
non-activated cells. Thus these two factors are distinct. This is not
completely unexpected, since carp (Cyprinus carpio) leukocytes have
been shown to secrete a lymphocyte growth factor which can induce
a proliferative response of purified lymphoblasts, but not freshly
isolated leukocytes (Caspi and Avtalion, 1984). Furthermore, the
activity of this growth factor was reduced following adsorption of
the factor-containing supernatants with mitogen-activated blasts
(Grondel and Harmsen, 1984).
The incomplete restoration of lymphocyte responses by the
polyclonal activating and IL-1-like factors suggest that other factors
or mechanisms may be required for inducing optimal PFC responses
in our assays. In mammalian systems, several species of accessory
cell-derived factors have been reported (reviewed by Corbel and
Melchers, 1984). IL-1 itself displays molecular heterogenity and
exists in high (35kD), low (17kD), and very low (4kD and 2kD)68
molecular weight forms (Oppenheim et al., 1986). In piscine studies,
LPS stimulated channel catfish monocytic cell lines have been shown
to produce and secrete high levels of high and low molecular weight
species of IL-1 that are active on both catfish andmouse T cells
(Vallejo et al., 1991). It is likely that LPS stimulation of rainbow
trout leukocytes results in the induction of a cascade of different
factors, similar to the acute phase response which has been studied
extensively in mammalian systems. The interrelationship of these
piscine accessory-cell derived molecules are not clear; whether they
display functional heterogeneity remains to be determined.
In piscine lymphocyte TI induced PFC responses IL-1 could
function indirectly by helping to initiatea cascade of T cell-derived
interleukins, or may function by directly inducing B cells to
differentiate into PFCs. Nevertheless, the PFCresponses of
lymphocytes supplemented with factor-containing supernatantswas
consistently less than the unfractionated leukocyte controls. There
are several possible explanations for this observation. First, some B
cells may respond to antigen plus IL-1 alone, whereas othersmay
require both IL-1 and nonspecific T cell factors. Alternatively, IL -1-
responsive and T cell factor-responsive B cells may be members of
nonoverlapping subsets. Finally, IL-1 may be required for the
generation of nonspecific T cell-derived cytokines. Thus the partial
restoration of PFC responses by the IL-1-like factor may be due to
its action on T cells, more specifically the induction of T cell
nonspecific factors. Nevertheless, strong support for a direct role of
IL-1 in mammalian B cell activation has been reported by Pike and
Nossal (1985) who demonstrated that IL-1 supports the growth and
differentiation of a portion of hapten-specific B cells cultured witha
TI antigen in the absence of accessory cells or additional cytokines.
However, this study has not attempted to address the precise
mechanism by which accessory cells may be induced to secrete IL-1.69
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Figure 3.1: Removal of LPS in TCM by filtration. Mitogenic
activity of tissue culture medium (TCM) supplemented with
increasing LPS doses before and after filtering (0.2pm). Mitogen-
induced proliferation (A) and anti-hapten plaque forming cell (PFC;
B) leukocyte responses were used toassess the effectiveness of
supernatant filtration. Leukocytes were cultured at 107 cells/ml in
100p1 TCM supplemented with 0.2pg /ml to 200pg /ml LPS.
Supernatants were either not filtered (II), filtered immediately
after addition of LPS ( MI; prefiltered),or filtered after 5 day culture
with LPS and leukocytes ( M, post filtered). PFC and mitogenassasys
were performed as described in the materials and methods section.
The PFCs and cpm were plotted for each medium tested. Each bar
represents the mean of three replicate cultures and theerror bar
represents one standard deviation from the mean.60000
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Figure 3.2: Effect of LPS dose response on factor production.
Supernatants generated from PBL stimulated with 0.2pg/m1to
200pg /ml LPS were assayed for accessory activity in lymphocyte
(macrophage-depleted) PFC responses. All supernatantswere
generated by culturing leukocytes in TCM supplemented with the
indicated doses of LPS for 4 days. Upon harvest, allsupernatants
were filtered with 0.2pm membranes to remove the LPS, and added
to lymphocytes upon initiation of cultures. Lymphocyteswere
cultured at 107 cells/nil in TCM supplemented with 50%supernatant
(by volume) in the presence () or absence (M) of antigen. The
number of PFCs generated per 106 cells was plotted for each
corresponding culture supernatant tested. Each barrepresents the
mean of three replicate cultures and the error bar represents one
standard deviation from the mean..8 2u
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Figure 3.3: The elution profile for biological activity in
fractionated supernatants. The molecular weight of active
fractions in 0.4pg /ml TNP -LPS ( 0 ), 0.2pg /ml LPS ( 0), and
200pg /ml LPS (M) derived supernatants were plotted in addition
to the protein standards (): alpha-lactalburnin (14.2kD), carbonic
anhydrase (29kD), ovalbumin (45kD), and bovine serum albumin
(66kD).74
Figure 3.4: Adsorption of high (A) and low (B) dose LPS-
derived supernatant accessory activity by incubation with
paraformaldehyde-fixed lymphocytes. Supernatants were
generated by culturing leukocytes at 107 cells/ml in TCM
supplemented with a high (200pg/m1) or low (0.2pg /ml) dose of
LPS, and harvested on day 5. Supernatants were then adsorbed with
108 three day antigen-activated (a) or non-activated ( a) and
paraformaldehyde-fixed lymphocytes. The supernatants were then
evaluated for accessory activity in lymphocyte PFC responses. For
comparison, the accessory activity of non-adsorbed supernatants
( tr) and red blood cell (-lk) adsorbed supernatants were also
determined. The percent of the maximum PFC response observed
(approximately 200 PFC per 106 cells) was plotted for each
corresponding volume of supernatant used to supplement
lymphocyte PFC responses. Each point represents the mean
percentage of three replicate cultures.U 100 wa
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Figure 3.5: Comparative kinetics of polyclonal activating and
IL-1-like factor generation. Factor containing supernatants
were generated by stimulating seven replicate leukocyte cultures
containing 107 cells in 1 ml TCM with a high (200pg/m1; circles) or
low (0.2pg/m1; triangles) dose of LPS. Each supernatant was
harvested on the appropriate day, then tested for activity in
lymphocyte PFC responses. Lymphocytes were cultured at 107
cells/m1 in 100p1 TCM supplemented with 50% supernatant (by
volume) in the presence (open symbols) or absence (filled symbols)
of antigen. Control supernatants generated from non-activated
leukocytes are represented by filled squares. The number of PFCs
generated per 106 cells was plotted for each supernatant tested.
Each point represents the mean of three replicate cultures and the
error bar represents one standard deviation from the mean.77
Figure 3.6: Titration of polyclonal activating (A) and IL -1-
like accessory (B) factors. Factor-containing supernatantswere
generated by stimulating seven replicate cultures containing 107
cells in 1 ml TCM with 200pg /ml or 0.2pg/m1 LPS. Supernatants
were harvested on day 1 (k), 2 (*), 3 (*), 4 ( 0), 5 (o), 6 (*),
or 7 (-+-). Lymphocytes were cultured at 107 cells/ml in 100p1 TCM
supplemented with 50% supernatant (by volume) and 0.4pg/m1
TNP-LPS. All cultures were harvested on day 9 and assayed for
anti-hapten PFCs. The percent of the maximum PFC response
(approximately 200 PFC per 106 cells) was plotted for each
supernatant tested. Each point represents the mean of three
replicate cultures and the error bars represent one standard
deviation from the mean.100,
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Units of Activityer ml
Day of
Harvest
High (200pg /ml)
dose LPS
Low (0.2pg.m1)
dose LPS
1 5 1
2 6 1
3 40 5
4 63 5
5 83 50
6 83 63
7 63 50
Table 3.1: Relative accessory activity of high and low dose
LPS-derived supernatants. The relative accessory activities of
supernatants harvested on days 1-7 was determined by titrating
the activity of these supernatants. The percent of the maximum PFC
response (approximately 200 PFC per 106 cells) was plotted for each
supernatant tested, and the relative activity of each supernatant
was estimated by determining the volume (p1) of supernatant
required to give a PFC response equal to 50% of the maximum PFC
response observed. This volume (obtained by interpolation of
volume of each curve giving 50% of the maximum PFC in figure 3.7)
was defined as 1 unit, and all values were converted to units per nil
(U/m1).80
Figure 3.7: The addition of high dose (A) and low dose (B)
LPS-derived supernatants to lymphocytes on days 0-8 of
the PFC response. Lymphocytes were cultured at 107 cells/ml in
100p1 TCM supplemented with ( III) or without (N) antigen. High or
low dose supernatant (100p1) was added to appropriate cultures on
days 0-8, and all cultures were harvested and assayed for PFCs on
day 9. The number of PFCs generated per 106 cells was plotted for
each corresponding day of supernatant addition. Each bar represents
the mean of three replicate cultures and the error bar represents
one standard deviation from the mean.150
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CHAPTER 4
Conclusions
Elucidation of the interactions between piscine leukocytes in
response to antigen has relied heavily upon defined hapten-carrier
systems, in vitro leukocyte culture systems, and cell partitioning
techniques, all of which were originally developed for mammalian
systems. Recent advances in piscine leukocyte culture systems
permit the use of limiting dilution analysis (LDA) as an alternative
method for assessing cellular cooperation between leukocytes upon
induction by antigen. This method, unlike the more conventional
methods used, allows for the elucidation of the sequence of B cell
maturation and antigen-induced differentiation associated with B
cell responses at both early and late phases.
In this study the ability of different subpopulations of
rainbow trout (Oncorynchus mykiss) peripheral blood leukocytes to
respond to the T-independent antigen trinitrophenylated-
lipopolysaccharide (TNP-LPS) was assessed by using an in vitro
passive hemolytic plaque assay. In chapter 2 it was demonstrated
that macrophages are required for providing an accessory function
during the antibody response to this antigen. Establishment of this
accessory function was demonstrated by showing that macrophages
(adherent leukocytes) were able to restore the capacity for antibody
production to purified lymphocytes (non-adherent leukocytes).
Furthermore, supernatants from antigen-stimulated macrophages
were sufficient to restore lymphocyte function. The use of limiting
dilution analysis confirmed this requisite role of the macrophage-
derived factor, revealed that the target of this factor(s) is the B cell83
precursor, and suggests that there may be differential sensitivity of
B cell precursors to this factor. Finally, the use of non-haptenated
LPS verified that LPS alone is the required stimulus for inducing
this factor. Based on the factor source, function, and molecular
weight it was suggested that IL-1 is the requisite accessory factor.
In chapter 3 a novel polyclonal activating factor was identified
by stimulating leukocytes with high doses of LPS. The activity of
this factor and the IL-1-like factor activity, as measured by the
provision of accessory function in lymphocyte PFC responses, is
produced as early as 24 hours and at optimal levels by day 5 post
LPS stimulation of leukocyte cultures. Stimulation with different
doses of LPS-generated supernatants with different activities, as
observed by polyclonal activation of lymphocytes. Stimulation of
leukocytes with a low dose (0.2pg/m1) of LPS induced the
production of the IL-1-like factor, whereas supernatants generated
with a high dose (200pg /ml) of LPS produces a factor which
induced polyclonal activation of lymphocytes. This difference in
activity was also demonstrated by the adsorption of supernatants
onto paraformaldehyde-fixed lymphocytes. High dose LPS
supernatant activity was reduced following adsorption with either
non-activated or antigen-activated lymphocytes, whereas low dose
LPS supernatant accessory activity was reduced only when
adsorbed with antigen-activated lymphocytes. This suggests that
lymphocyte surface receptors for the polyclonal activating factor are
present on both antigen- and non-activated lymphocytes, while only
activated lymphocytes express a surface receptor for the IL-1-like
accessory factor. Finally, the addition of factors to cultures at later
stages of the PFC response decreased its activity in lymphocyte PFC
responses. The similarities of this trout IL-1-like factor and
mammalian IL-1 have been discussed, and it has been proposed
that this is the first demonstration of a salmonid monokine
analogous to mammalian IL-1 as well as a newly identified cytokine
which both affect B cell function.84
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APPENDIX 1
Reagents and Buffers
Benzocaine. Fish were anesthetized by immersion in a benzocaine
bath of approximately 2 ml stock solution/4 liters of water. The
stock solution was prepared by dissolving 10 grams ethyl-p-
aminobenzoate in 100 mis of 95% ethanol (Kaattari and Irwin,
1985).
Cacodylate buffer. A solution of 0.28 M Cacodylate buffer was
prepared as described by Rittenberg and Amkraut (1966), by
dissolving 3.82 grams of cacodylic acid (Sigma, St. Louis, MO) in 100
ml distilled water. 1N sodium hydroxide was used to adjust the pH
to 7.0. Cacodylate buffer was stored at 4°C for no longer than one
month.
Modified Barbitol Buffer (MBB). A stock solution of 5X MBB was
prepared by dissolving 1 vial (0.05 moles sodium barbital, 0.01
moles barbital) barbital buffer (Sigma) in one liter of distilled water
at room temperature with constant stirring. Anhydrouscalcium
chloride (0.083g/1), magnesium chloride (0.508 g/1), and sodium
chloride (42.5 g/l) were then added, and the pH adjusted to 7.4. The
5X stock solution was autoclaved and stored at 17°C. A 1X working
solution was prepared by dilution with filter sterilized saline (8.7
g/l).
Phosphate buffered saline. Phosphate buffered saline (PBS) was
prepared by dissolving 1 gram of monobasic potassium phosphate
(KH2PO4) and 17.8 grams of dibasic sodium phosphate-7 hydrate110
(Na2HPO4-7H20) in one liter of distilled water. To this solution 8.5
grams of sodium chloride was added and the pH adjusted to7.4.
Trinitrophenylated lipopolysaccharide (TNP-LPS). TNP-LPS was
prepared by the method of Jacobs and Morrison (1975). 161 mg of
E. coli serotype 055.B5 lipopolysaccharide (Sigma) was suspended in
cacodylate buffer (8.05 ml), with constant stirring. The pH of the
solution was adjusted to 11.5 with 10 N sodium hydroxide. The tube
was foil-wrapped and picrylsulfonic acid (96mg dissolvedin 8m1
cacodylate buffer) was added dropwise with constant stirring. The
solution was stirred for two hours at room temperature. This
solution of TNP-LPS was then dialyzed against 4 ( I liter) changes of
saline, and one (1 liter) change of RPMI-1640. TNP-LPS was
pasteurized for 45 minutes at 70°C. Stock TNP-LPS was stored at
4°C, and diluted in RPMI just prior to use.
Complement. Sera was obtained from spawned adult steelhead
trout and used as the source of complement. Blood was collected in
50 ml centrifuge tubes, held on ice and allowed to clot overnight at
4°C. The sera was removed and pooled, then divided into aliquots
which were stored at -70°C until used. Complement was diluted with
MBB prior to use in the plaque forming cell assay.111
APPENDIX 2
Sheep Red Blood Cell (SRBC) Haptenation
Trinitrophenylated SRBCs were prepared using a modification
of a method described by Rittenberg and Pratt (1969). SRBCs were
washed 3X in lx MBB by centrifugation for 5 minutes at 500 x g. To
the wet packed SRBCs (1 ml), a solution of 200 p1 picrylsulfonicacid
in 3.3 ml cacodylate buffer was added dropwise. The tube wasfoil-
wrapped and placed on a rotator for 20 minutes at room
temperature. The SRBC solution was centrifuged,the supernatant
removed and a solution of 0.0037 g of glycyl-glycine dissolved in
5.8 ml MBB was added to block the remaining active sites. Thecells
were centrifuged again, supernatantremoved, then washed 3X in
MBB. The SRBCs were then resuspended to a concentration of20%
(by volume) in MBB for final dilution.